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“Interdependent relationships involve the willingness and ability to give to others 
 and accept from them aspects of all that one has to offer such as love, respect,  
value, nurturing, knowledge, skills, commitments, material possessions, time and  
talents”. (Roy & Andrews, 1999, p. 111).   
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It is estimated that three million people in the United States are on oral anticoagulation 
therapy (warfarin). Populations studied have been found in therapeutic range 64% of the 
time (Pernod, Labarere, & Bosson, 2008). The low percentage of therapeutic range is 
attributable to (a) adherence, (b) monitoring infrequency, (c) Vitamin K antagonists, and 
(d) the effects of aging and comorbidities. The purpose of this evidence-based practice 
(EBP) project was to examine whether an educational intervention would improve the 
knowledge of patients receiving warfarin therapy. Roy’s model for patient adaptation and 
the Stetler Model for EBP were used as frameworks for the project. A pretest/posttest 
design was used over a 2-week period that included 38 patients aged 42 through 90 (M 
= 74.7, SD = 10.1). An educational intervention done by the project manager using a 
booklet, video, and food models on warfarin therapy was completed after the pretest. 
Patients’ INR (International Normalized Ratio) values were tracked at pretest, posttest, 
and every two weeks for twelve weeks. A paired sample t test found a statistically 
significant difference between the pre- and posttest scores. The mean pretest score was 
11.11; SD = 2.35 compared to the posttest mean score of 12.48; SD = 1.45; (t (37) = -
4.215, p < .001). No significant difference from pretest INR to posttest INR was found (t 
(26) = -2.002, p > .056). A Cochran’s Q test showed INR results from 4 to 12 weeks 
were not statistically significant (x²(4) = 4, p > .406). Results demonstrated that an 
educational intervention improved patient knowledge, but the intervention did not 
improve the patients’ INR values over two weeks, or over the four to 12 week time 
frame. There were no trends over time, other than to support the literature of a low 
percentage of the population in therapeutic range. Replication of this EBP project has 
been patterned by the project manager’s institution. 




One of the roles of the advanced practice nurse (APN) is to implement evidence-
based practice (EBP) in the clinical setting.  Evidence-based clinical decision making 
leads to improved patient health and safety outcomes. EBP also decreases patient 
morbidity and mortality while reducing healthcare costs. Finally, EBP minimizes 
geographic differences in patient care delivery (Melnyk & Fineout-Overholt, 2011). 
 Interpreting EBP involves multiple steps. These steps include (a) formulating the 
urgency of inquiry, (b) presenting the clinical question through current practice and 
patient welfare, (c) locating the most relevant and best evidence in the medical literature, 
(d) incorporating clinical practice and patient preferences with best evidence to influence 
a change in practice, (e) evaluating the outcomes based on the evidence, and (f) sharing 
the outcomes so that more may have the knowledge of best practice results for both 
patients and providers. The clinical question is then answered (Melnyk & Fineout-
Overholt, 2011). Each of these steps is addressed throughout this project.  
 Oral anticoagulation therapy (OAT) is patient use of generic warfarin or its brand 
name, Coumadin® by prescription for the purpose of prevention of stroke for patients 
with thromboembolic heart disease. Examples of thromboembolic heart disease include 
atrial fibrillation or flutter, cardiomyopathy, valvular heart disease, mechanical heart 
valve replacement, coronary artery disease, or myocardial infarction (Engelke, 2012). In 
addition, OAT is used in clinical practice for the purpose of dissolving emboli and emboli 
prevention for patients with pulmonary emboli, deep vein thrombosis or ischemic stroke 
(Engelke, 2012; Wilson, Racine, Tekieli, & Williams, 2003). In summary, OAT is used to 
help prevent blood clots, dissolve current clots or prevent clots from occurring in 
cardiovascular disease. The physiology of OAT is a Vitamin K antagonist. OAT 
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suppresses the Vitamin K coagulation in the liver, causing the blood to be thinner 
(Wilson, et al., 2003). 
 It is estimated that two million patients each year begin OAT world-wide 
(Banerjee & Lip, 2011). There are approximately three million people taking OAT in the 
United States (Kirsch, 2011). However, only 50% of the population in the United States 
is in the therapeutic INR (International Normalized Ratio) range (Kirsch, 2011). The low 
percentage of patients on OAT in the therapeutic range is attributable to inconsistency of 
the INR laboratory value of these patients (Banerjee & Lip, 2011). Inconsistent INR can 
be due to (a) failure of patients to dose OAT as prescribed, (b) lack of patient 
participation in medical monitoring, (c) inconsistent intake of Vitamin K antagonist by the 
patient in consumed food, beverage or medications, or (d) the effects of patient aging 
and comorbidities (Banerjee & Lip, 2011). The majority of these factors can be related to 
the patient’s understanding of OAT.  An understanding of what influences these factors 
is essential in providing safe and effective care.   
 The patient’s knowledge of OAT, specifically warfarin or the name brand, 
Coumadin®, was assessed in the APN’s clinical agency in order to achieve improved 
patient outcomes. Improving outcomes also facilitated patient satisfaction by (a) having 
more INR tests in the therapeutic range, (b) increasing the time between INR testing by 
1, 2 or 3 weeks, (c) avoiding patient emergency room visits from excessive bleeding or 
embolic symptoms, and (d) reducing hospitalizations related to bleeding or embolic 
formation. Keeping patient INR values in the therapeutic range assisted the clinic to be 
more efficient. More INR values in therapeutic range also provided greater professional 
staff job satisfaction implementing and maintaining an effective patient education 
program. Patient adherence with medication dosing and laboratory monitoring was 
necessary to safely manage OAT patients. 
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Background 
 Patient education regarding OAT contributes to the patient’s knowledge and 
safety.  Inadequate patient education, poor understanding of the medication’s action or 
non-adherence with OAT can lead to adverse events. Patients who have a poor 
understanding of OAT and its adverse effects are more likely to be non-adherent than 
those who receive education (Ryan, Byrne, & O’Shea, 2008). For example, it is noted 
that patients stating they had no education relative to warfarin therapy spent only 20% of 
their time in a therapeutic range during laboratory surveillance (Ryan et al., 2008).  
 For high risk groups such as the older adult, the lack of understanding of OAT 
can be a major barrier to effective health care. The older adult is at greater risk due to 
multiple comorbidities such as hypertension and obesity. In addition, due to diminished 
cognitive functions such as concentration, word recognition or adequate vision, the older 
adult may not display adequate knowledge of OAT (Wilson et al., 2003). Much of OAT 
information is written at a higher educational level than the patient’s comprehension 
(Clarkesmith, Pattison, Lip, & Lane, 2013). This learning barrier puts the older adult, or 
any patient who does not comprehend the information, at greater risk for adverse 
medication reactions. Furthermore, learning barriers place the patient at a generally 
higher health risk and increase the likelihood of hospitalization (Cook-Campbell & 
Sefton, 2010).  
 The participating group for the OAT project was 38 clinic outpatients on OAT 
ranging in age from 42 to 90 who have thromboembolic heart disease. These diseases 
include atrial fibrillation or flutter, cardiomyopathy, valvular heart disease, heart valve 
replacement or coronary artery disease. Patients on OAT who have chronic deep vein 
thrombosis, pulmonary emboli or ischemic stroke were also in the participating group.  
 The educational intervention was applied to patients on OAT in this project. 
Patient information for the educational intervention included how the OAT interferes with 
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the body’s blood clotting abilities, particularly preventing formation of a blood clot, 
disrupting an existing clot or treating conditions that cause blood clots. Within this blood 
thinning mechanism, patients needed to understand OAT’s purpose, administration, 
laboratory values, dietary guidelines, safety precautions and adherence. In addition, 
patients had necessary close medical surveillance to help avoid complications of 
bleeding or clot formation (Holbrook et al., 2012).  
History of Warfarin  
 Warfarin’s pharmacologic potency was originally found in plants. In the 1920’s, 
cattle in the Canada and the Northern United States were discovered to have ingested 
moldy silage made from sweet clover (Melilotus alba and Melilotus officinalis) 
(Pirmohamed, 2006). A researcher located in North Dakota, L. M. Roderick, found the 
silage contained a hemorrhagic property that reduced the activity of prothrombin, which 
is a blood clotting factor (Engelke, 2012; Pirmohamed, 2006).  In 1940, Karl Link and his 
student, Harold Campbell, discovered the anticoagulant in the sweet clover in Wisconsin 
was 3.3’-methylenebis (4-hydroxy coumarin) (Pirmohamed, 2006). Continued work by 
Link lead to the synthesis of warfarin in 1948. Warfarin was approved in 1952 as a 
rodenticide in the United States. It was approved for human use in 1954 to prevent 
stroke (Engelke, 2012). The name warfarin is derived from the Wisconsin Alumni 
Research Foundation (WARF) and from the chemical name, coumarin (-arin). (Agnesian 
HealthCare, 2011; Pirmohamed, 2006).  
Why OAT Education is Important  
 As the first oral thrombin inhibitor, warfarin is the most widely prescribed 
anticoagulant. Warfarin is the most cost-effective and physiologically-effective 
medication world-wide for preventing embolic strokes in patients with atrial fibrillation 
(Pirmohamed, 2006). Warfarin education should start when the medication is prescribed. 
OAT education can begin in the hospital, clinic office, or home setting. This education 
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should include the purpose of OAT, its risks and benefits, and the name, dose, route, 
schedule, and side effects of the medication. Dosing directions also include what to do if 
a dose is missed. The patient learns about safe blood monitoring called International 
Normalized Ratio (INR) with the warfarin education (Holbrook et al., 2012). The INR 
numerical range conveys information and education to the patient of current OAT 
control.  Food and drug interactions plus self-care safety such as wearing gloves when 
gardening or avoiding situations that could cause injury are important information for 
patients on OAT. Patients also need to know whom to call if they have questions or 
concerns (Engelke, 2012).  
Assessing OAT Adherence   
 Objective ways of assessing OAT patient adherence is performed with various 
assessment tools. Assessment of patient adherence is necessary for a variety of 
reasons. Such reasons include inquiring if the patient is using other medications that 
interfere with the action of OAT. Dosing OAT can be affected by the patient’s alcohol 
intake, taking extra or omitting doses, or the addition or discontinuance of antibiotics 
(Huber, Levett, & Atkinson, 2008). Seasonal foods can also affect the patient’s 
compliance with OAT. For example, fresh green vegetables seem a healthy alternative 
to many food choices; however, green vegetables contain Vitamin K antagonists which 
contribute to the ineffectiveness of OAT (Engelke, 2012).   
 Medical literature described the use of assessment questionnaires to determine 
patient adherence with OAT (Huber et al., 2008; Palareti et al., 2005; Wilson et al., 2003; 
Zeolla, Brodeur, Dominelli, Haines, & Allie, 2006). These questionnaires include the 
Warfarin Compliance-Assessment Scale (Huber et al., 2008) and the Questionnaire on 
Comprehension of Oral Anticoagulant Treatment (QCOAT) (Palareti et al., 2005). 
Additional OAT assessment questionnaires include the 20-question Knowledge 
Information Profile (Wilson et al., 2003), the 14-question Knowledge Information Profile-
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Coumadin® (Nordstrom, Wilson, Templin, & DiNardo, 2009) and the Oral 
Anticoagulation Knowledge test (Zeolla et al., 2006). 
  Patient assessment questionnaires measure the patient’s comprehension. 
Assessment questionnaires can also serve as part of the teaching intervention. Such 
questionnaires can measure how the education needs to be tailored to each patient 
producing improved outcomes for the patient. The questionnaires serve as a reminder to 
the patient of OAT adherence. As the patient’s learning needs are evaluated by an 
assessment questionnaire, responses to the questionnaire can provide documentation of 
the patient’s comprehension and be scored numerically. Improved patient adherence to 
diet and medication knowledge practices leads to more INR laboratory values in the 
therapeutic range. Determination of the patient’s safety with OAT and adherence is 
consistently required throughout the patient’s lifetime dosing (Mazor et al., 2007). This 
EBP project used the Knowledge Information Profile-Coumadin® scale (KIP-C) for the 
assessment questionnaire (Nordstrom, et al., 2009).   
Statement of the Problem 
 Patients failing to take OAT as prescribed may do so for a variety of reasons 
(Engelke, 2012). Failure to take the OAT may result from the inability to refill the 
prescription due to a lower socioeconomic status or no health insurance. If the patient 
has a lower educational background, the patient on OAT may be unable to read the label 
or write down directions for dosing (Engelke, 2012; Wilson et al., 2003). Dosing errors 
include forgetting the dose or taking an extra dose. Patients may believe that OAT 
caused a previous stroke or trans-ischemic attack. In addition, patients may attribute an 
adverse reaction to OAT, such as blood loss through the mouth, nose, ear, stool, or 
urine (Engelke, 2012).  
 Patients may miss INR checks due to cost concerns or inconvenience of getting 
to the lab or clinic for blood draws. Frustration of not achieving a therapeutic INR can be 
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a cause of non-adherence (Engelke, 2012; Woten, 2013). Individual lifestyle patterns of 
work or family commitments may interfere with getting to the lab or clinic. The INR check 
may not be considered a priority or its importance not known to the patient (Clarkesmith, 
Pattison, & Lane, 2013; Engelke, 2012).  
 Patients on OAT can be unaware of food and beverage changes which impact 
anticoagulation. Patients can be unsure of food sources of vitamin K. Food sources of 
vitamin K are not only in green leafy vegetables but also in grapefruit, pomegranate, 
cranberry, oils, margarine, and salad dressings (Huber et al., 2005). The food listing may 
not be logical or easy for the patient to remember. Beverages such as green tea contain 
Vitamin K. More than two drinks per day of alcohol interfere with the effectiveness of 
OAT (Tom, 2005). High protein diets have an anticoagulation lowering effect (Huber et 
al, 2005). Individuals on OAT who consume a high protein diet have an increased 
albumin which causes an increase in protein-binding warfarin. This binding causes less 
free warfarin available for an anticoagulant effect, thus causing a lower INR (Tom, 2005).       
 Cold medications, stomach remedies, pain relievers, and dietary supplements 
interfere with OAT (Smith et al., 2010). Over-the-counter medications such as ibuprofen 
and naproxen are classified as non-steroidal anti-inflammatory drugs (NSAIDS) and 
have their own anticoagulation effect.  With 20% of the population of the United States 
using a supplemental product, patients have a lack of awareness of the pharmacologic 
properties of vitamins and supplements (Smith et al., 2010). Many supplements increase 
the bleeding risk by interacting with OAT.    
 The final problem of inconsistent INR results is that the patient’s knowledge of 
OAT can vary with age and comorbidities. Older patients often demonstrate poor 
knowledge of OAT which places patients at increased risk for bleeding, poor compliance, 
and poor control (Hu, Chow, Dao, Errett, & Keith, 2006). In a previous study, Hu et al. 
(2006) described older patients who have a limited income, reported a lower educational 
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level, and did not work outside the home scored lower on OAT knowledge tests. In 
addition, medication interactions, appetite changes, and poor medication compliance are 
risk factors for older patients. Inadequate teaching or using teaching tools above the 
patient’s reading ability may also lead to poor patient outcomes (Wilson et al., 2003).   
 In summary, multiple factors can attribute to the INR not being in the therapeutic 
range. Patients may demonstrate (a) a lower educational level, (b) poor knowledge base 
of OAT, (c) a lack of education on OAT, and (d) medication non-adherence. Health 
beliefs regarding OAT are a barrier. Consistent food, beverage, and medication intake 
are not well understood by patients on OAT (Hu et al., 2006). Additional factors placing 
the patient at greater risk for bleeding include multiple comorbidities and effects of the 
aging process (Hu et al., 2006).      
Data Included from the Literature Supporting the Need for the Project 
Studies in the current literature stated that patient education is needed to 
promote adherence and prevent complications in the population on OAT.  However, this 
education is often lacking.  Lowthian et al. (2009) interviewed 40 patients on OAT and 
their physicians. These physicians consisted of 35 general practitioners and one 
specialist. Of the 36 physicians who were interviewed, 12 were unaware their patients on 
OAT had multiple problems, such as depression and medication non-adherence. Only 
five of the 36 physicians in this study believed they had responsibility for their patient’s 
education of OAT; 15 physicians believed it was up to the laboratory services to do the 
OAT teaching; and 16 physicians acted only to refer the patient to another provider who 
treated the patient’s pathology and ordered the OAT. Of the 36 physicians interviewed, 
only 14 reported conducting any patient education at the beginning of the patient’s OAT 
(Lowthian el al., 2009). The authors stressed the importance of the patient’s knowledge 
of OAT should be assessed when OAT was initiated. Ongoing OAT education was 
addressed as very important to maintain sustained INR values. The ongoing education 
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was directed by the primary physician during regular office visits. Another solution was to 
direct an advanced practice nurse for high-risk patients to assess the patient and provide 
OAT education during regular office visits (Lowthian et al., 2009).   
 Palareti et al. (2005) studied risk factors for highly unstable response to OAT. 
Insufficient knowledge of OAT’s action was a risk factor. Patients not knowing or 
following the rules of treatment nor monitoring were added risk factors. The authors 
recommended standardized criteria for patients with great variability in their unstable 
INR values.   
 A case-control study by Palareti et al. (2005) included matched cases (77) and 
stable controls (80) that were followed over four months. The primary goal of the study 
was to determine patient factors for INR stability. The second aim of the study was to 
examine how anticoagulation clinics evaluated the INR stability in comparison to 
standardized criteria. Palareti et al. (2005) found a larger number of unstable cases were 
unaware of why they were prescribed OAT. The patients in the matched cases group did 
not understand the action of OAT and its side effects. A scored questionnaire and 
patient interviews were completed during this case control study to discover these facts. 
An interview was conducted with a physician who focused on correcting the wrong 
answers to the questionnaire and used the interview as an educational intervention.  
Palareti et al. (2005) found that participating in the study had a positive educational 
effect on the patients in the uncontrolled group. The INR stability improved over the next 
four months. In addition, the patient education also reduced the risk of major bleeding in 
the unstable cases cohort.   
 Patient knowledge through education of OAT therapy and its management from 
the OAT clinic was attributed to improved INR control (Palareti et al., 2005). The 
percentage of time spent within the therapeutic range improved (61.6% vs. 38.8%, p = 
0.0001) over the four months following the intervention. Time spent below the 
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therapeutic range improved significantly (33% vs. 17%, p = 0.013). INR control improved 
above the therapeutic range also improved significantly (25% vs. 12%, p = 0.0002). The 
researchers further concluded good OAT clinic management includes (a) assessment of 
the patient, (b) an intervention such as the questionnaire, (c) knowledgeable dosing, (d) 
continued education by assessment, and (e) an interview as a teaching intervention for 
patients who are uncontrolled (Palareti et al., 2005). 
 Literature indicated that patient knowledge of OAT varies with age. Elderly 
patients (>75 years) generally demonstrate poorer knowledge of OAT (Clarkesmith, 
Pattison, and Lane, 2013). Patients in this age group on OAT should attend the clinical 
agency every three months for surveillance in weight, for determination of medication 
tolerance, and for review of consulting physician findings. In addition, conversation 
during the appointment should address any unreported bleeding incidents, laboratory 
values, and general well-being. With surveillance of the older adult patient’s weight, 
discussion leads to appetite and eating habits. A change in eating habits including a 
decline in appetite can cause the INR to decrease below therapeutic levels due to the 
body’s absorption pathways (Woten, 2013). Time spent with patients measuring their 
knowledge base and discussion during their office appointments can help improve their 
knowledge, attitudes and practices.  
Data Included from the Clinical Agency Supporting the Need for the Project  
The clinical agency was a satellite clinic of a regional medical center.  The 
medical center is located in a Midwestern city which has a population of 113,040. 
Licensed for 325-beds, the not-for-profit medical center serves a six county area. 
 The clinical agency was a primary care office located seven miles north of the 
medical center where 3500 patients are registered. The patients are all adults and 
geriatric patients.  Sixty-five patients with indications for OAT related to their 
cardiovascular conditions were patients at the clinic. These patients ranged in age from 
THE EFFECT OF AN EDUCATIONAL INTERVENTION ON OAT                          11 
 
42 to 90.  Of the patients on OAT, 50 had their OAT managed in primary care, while the 
additional 15 OAT patients had another consulting provider manage their OAT.  
 The clinical agency used dosing guidelines from the Dosage Adjustment 
Algorithms of the Point of Care Guides, based from the American College of Chest 
Physicians clinical guidelines (Ebell, 2005; Holbrook et al., 2012). Patients are tracked 
from one INR to the next ordered INR. The clinical guidelines recommend healthcare 
providers who conduct anticoagulation therapy conduct this in a systematic manner 
(Holbrook et al., 2012). Recommendations include baseline INR, plus tracking in four 
days as a therapeutic INR level can be achieved in 96 hours (Ludwig, 2008). For a target 
INR of 2.0 to 3.0, the dose is increased by 10% with the next INR check in four to eight 
days if the INR is less than 1.5. Another increase of the dose by 10% is given with the 
next INR check in seven days if the INR is 1.5 to 1.9.  Patients whose INR is 2.0 to 3.0 
have no change in their dosing. The next INR is requested as the number of consecutive 
in-range INR’s increase in one week increments, the maximum time between testing is 
four weeks (Ebell, 2005; Holbrook et al., 2012). 
 One difficulty experienced by the clinic is that concomitant disease processes 
may take the clinic’s patient to the emergency room for treatment. When patients are 
later seen in the clinical agency, the patient on OAT is often found to have been 
prescribed a medication that affects the action of OAT by emergency room staff. The 
clinical agency corrects this prescription error, facilitating the patient back to a safer and 
therapeutic INR without adverse bleeding or clotting events.     
 Another difficulty is attempting successful call-backs for patient questions 
regarding OAT.  One full-time physician, one full-time nurse practitioner, and one part-
time nurse practitioner work in the clinical agency. In addition to scheduled patient visits, 
the providers return over 40 patient calls daily to help trouble-shoot various patient 
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problems and concerns. Five to ten phone calls daily are patient-related calls to OAT 
(agency nurse practitioner, personal communication, April 3, 2013).  
 Still another difficulty for the clinical agency is patients on OAT who are 
prescribed medications by other providers that interfere with OAT therapy. Examples of 
this documentation included two-week antibiotic therapy from infectious disease 
physicians or nine-month antibiotic therapy from urology practices.  Orthopedic groups 
use non-steroidal anti-inflammatory drugs (NSAIDS) which also interfere with OAT.  
Clinical agency experience also included patients having chemotherapy prescribed by 
oncology practices with resulting INR values out of the therapeutic range (agency nurse 
practitioner, personal communication, April 17, 2013).   
 The clinical agency’s patients on OAT also presented with new over-the-counter 
medications that were not previously on the office medication list for that patient.  
Examples of these were ginseng, garlic, green tea, ginkgo biloba, and St. John’s Wort 
which have the potential to interact adversely with OAT (Agnesian Healthcare, 2011).  
Patients often announced they were taking an over-the-counter medication to self-
medicate another healthcare issue, only to find this was not part of OAT adherence.  
 In addition, three or 6% of the clinic’s patients on OAT were in the emergency 
room with bleeding and lacerations during the period from August, 2013 through 
September, 2013. One of the emergency room visits included a fatality (agency nurse 
practitioner, personal communication, August 21, 2013).     
 Current practice for inpatient or outpatient education throughout the medical 
center and its clinics is to utilize patient education materials specific to disease-oriented 
diagnoses (Dugdale, 2013).These are generic computer-based information sheets of 
patient education information written on the ninth grade reading level in two-point font 
(Dugdale, 2013). The generic computer-based information sheet does not contain any 
pictures. There is also an eight-page booklet on warfarin therapy. The booklet is written 
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on the ninth-grade reading level with twelve-point font and used in the outpatient setting 
(Ludwig, 2008). It does not contain pictures for easier patient recall (Ludwig, 2008). The 
booklet does not contain safety measures for the patient to help prevent indoor or 
outdoor injury (Ludwig, 2008). The booklet does not address diet changes or a weight 
loss plan, seeing other providers, or address specific medical conditions for taking OAT 
(Ludwig, 2008).  
 The medical center currently has 459 policies and procedures mentioning OAT.  
Within the 459 policies and procedures, general medication teaching about initiation of 
any new drug is addressed regarding indication for use, dosing and side effects. Policies 
and procedures indicate that general drug education should be reviewed with the patient 
upon discharge, in hospital-based specialty clinics, and during home care (Cook-
Campbell & Sefton, 2010).  However, there are no specific policies and procedures on 
OAT initial or continuing education in the clinical agency or medical center. There is also 
no current measurement of patient knowledge or follow up intervention to promote OAT 
education performed consistently in the clinical agency or at the medical center.   
Purpose of the EBP Project 
 The purpose of this EBP project was to provide an educational intervention for 
the clinical agency’s patients using warfarin or Coumadin® in an effort to improve their 
basic knowledge of OAT safety and the efficacy of OAT for the patient. Patients 
participating in the project increased their knowledge after the educational intervention. 
The Knowledge Information Profile-Coumadin® (KIP-C) (Nordstrom et al., 2009) 
assessment questionnaire was measured by posttest scores. Additional factors 
measured included the patient’s level of education, gender, indications for OAT, if the 
patient had ever had education previously on OAT, and how long ago the patient had 
previous education on OAT. Further demographics included the patient’s duration of 
therapy using OAT and whether the patient had a spouse or significant other listening to 
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the instruction. Finally, the project measured the impact of food selections, beverage 
interactions, and interactive medications.   
Identification of the Compelling Clinical Question 
The compelling question is:  What is the effect of an educational intervention on 
oral anticoagulation therapy knowledge for adult patients on OAT in primary care? 
 PICOT format.  EBP involved developing the clinical question using the PICOT 
format. PICOT is an acronym of (P), patient population, (I), intervention of interest, (C), 
comparison of the intervention, (O), outcome, and (T), time frame. The acronym is based 
on clinical question components from Melnyk and Fineout-Overholt (2011). Applying 
PICOT, the compelling question becomes:  Among clinic patients taking warfarin or 
Coumadin® in primary care (P), what is the effect of an educational intervention with one 
follow up contact two weeks after the intervention (I), compared to pre-intervention oral 
anticoagulation therapy knowledge (C) affecting  the INR consistency in the narrow 
therapeutic range (O) within two weeks (T)?  Two weeks will be used to allow sufficient 
lag time for the INR to change based on patient behavior. The lag time allows for a more 
valid measure, that is, did the tool measure what it was intended to measure (Stiggins, 
1987)?  In addition, did the patient’s behavior change due to the intervention (Stiggins, 
1987)?  It is not realistic to expect significant change of behavior in a shorter time frame 
because the patient needs time to implement the changes in foods, beverages, or 
medications that were learned during the intervention. In addition, it takes approximately 
three to five days for the INR to adjust to changes to anticoagulation dosing or diet 
sources (Ebell, 2005). Patients who implement the behavior changes would facilitate an 
improvement in the INR in the therapeutic range (Stiggins, 1987). Further psychometric 
evaluation of the KIP-C will be discussed in Chapter 2.     
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Significance of the EBP Project 
 The Joint Commission identified anticoagulants as one of the top five drugs 
associated with patient safety issues in the United States (Engelke, 2012).  Major 
bleeding occurs in >2% of the patients using OAT.  OAT-associated cerebral 
hemorrhage can recur in 22% of patients after restarting OAT (Engelke, 2012; Palareti & 
Cosmi, 2009). In patients over age 80, risk factors for major bleeding include insufficient 
patient education and polypharmacy (Engelke, 2012). Less than 50% of patients on OAT 
are able to maintain the stability of their target INR (Kirsch, 2011). Being out of 
therapeutic range puts patients using warfarin or Coumadin® at risk for either bleeding 
or embolism.  
 Because teaching the patient on OAT is time-consuming for clinicians and 
overwhelming for patients, OAT education is often omitted. Strategies to find the most 
effective and consistent patient education methods for patients were located in the 
literature for this EBP project. Teaching approaches for the clinician are also identified in 
the literature. Clarkesmith, Pattison, and Lane (2013) cited patients on OAT may have 
very little knowledge or comprehension of their medication as well as the disease for 
which the OAT is prescribed. The patient may not understand the scope of the disease, 
nor understand the risks and benefits of OAT therapy. This project addressed these 
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CHAPTER 2 
 FRAMEWORKS AND REVIEW  
 The frameworks guiding this project included the Roy Adaptation model 
addressing patient characteristics and behaviors of adaptation. The Stetler model of 
EBP was utilized for problem-solving by the clinician.   
Roy’s Adaptation Model  
 
 Theoretical framework description.  The theoretical nursing model used to 
guide this project was Sister Callista Roy’s Adaptation model. Roy’s model originated 
when she worked as a pediatric nurse (Phillips, 2010). As a pediatric nurse, she noted 
the resiliency of children and their ability to adapt to psychological and physical changes 
when hospitalized. Later in her graduate studies, Roy utilized adaptation as the 
foundation for her conceptual framework (Phillips, 2010).  
 The adaptation framework focused on three effects of stimuli encountered by the 
individual (Roy, 2011). These effects included focal stimuli, contextual stimuli, and 
residual stimuli (Roy, 2011). Within adaptation, focal stimuli described the immediate 
stimuli facing the individual (Phillips, 2010). The contextual stimuli translated to the 
multiple factors or circumstances that add to the impact of the immediate or focal stimuli 
(Roy, 2011). Residual stimuli encompassed characteristics of the environment, which 
may or may not influence the individual’s circumstance (Phillips, 2010).  
 The three effects of stimuli within adaptation fit well with the patient using OAT. 
The focal stimulus for the patient was learning the disease process which included the 
need for OAT.  Contextual stimuli combined the impact of the cardiovascular process 
requiring OAT plus utilizing OAT and its side effects. Residual stimuli for the patient on 
OAT were environmental factors such as the interaction of lifestyle, foods, or other 
medication. As the patient learned how to manage the effects of residual stimuli by 
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incorporating foods, lifestyle and prescribed medications, the INR’s therapeutic range 
was achieved by the patient. The therapeutic INR range promoted disease process 
stability with less likelihood of clot formation or bleeding.  
 Roy’s (2011) four adaptation modes of physiological, self-concept, role function 
and interdependence integrated well with the patient using OAT. The patient on OAT 
found physiological integrity compromised with an illness or disease process requiring 
OAT. Self-concept was challenged as the patient learned new skills and the importance 
of adherence to a new medication therapy. The patient entered into a new role function 
of integrating the disease process with the medication for OAT to improve or sustain life. 
Adaptation continued as the patient identified physiological integrity, improvement in 
self-concept and OAT adherence. Interdependence in patients on OAT allowed the 
patient to acquire knowledge and skills through providers. Interdependence disclosed 
relationships with family and friends, and demonstrated significant behaviors that 
contributed to the patient’s health using OAT. The patient flowed through these modes 
which are perceived as adaptation (Phillips, 2010).  
  Application of theoretical framework to EBP project. Roy’s theoretical 
framework was effectively applied in this project of determining the educational 
intervention of OAT. Patients understood their cardiovascular condition put their health 
at risk. Poor patient understanding surrounding the cardiovascular condition and its 
treatment contributed to the patient’s likelihood of not adhering to recommendations.  
The project on OAT assisted the patient with understanding both the disease process 
and its treatment. In addition, the project facilitated the patient’s adaptation with multiple 
health issues.  
 Clinic patients using OAT who participated in the project took the standardized 
pretest including eight questions of demographics to assess their knowledge of OAT.  
The eight questions of demographics were age range, gender, level of education 
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achieved, if the patient ever had education on OAT, how long ago was the OAT 
education, length of time using OAT, indication, and was there a significant other also 
listening to the education. The teaching intervention consisted individually discussing the 
pictorial handout Blood Thinner Pills: Your Guide to Using Them Safely (Huber, 2005) 
with the patient plus showing food models during the discussion. In addition, the 
teaching intervention included answering all questions which the patient may have about 
the pretest, the pictorial booklet and the food models. The patient then watched a 12-
minute video on OAT. Both the pictorial booklet as well as the video was sent home with 
the patient.  As described in Roy’s Adaptation model, patient integrity improved as 
patients learned of their cardiovascular condition and why OAT was prescribed. Self-
concept expanded as the patient comprehended the impact of OAT by consuming 
consistent daily food and beverages containing Vitamin K. Role function of the patient on 
OAT was enhanced as the patient experienced INR testing with more consistent 
therapeutic values. Interdependence between nursing and the patient was fostered by 
the educational intervention, the need for monitoring surveillance, and INR stability.   
 Since Roy’s theory of adaptation applied to outcomes, the patient took the 
standardized posttest two weeks after the educational intervention. A two-week time 
period provided validity since it provided enough time to measure significant changes in 
patient behavior and the INR within therapeutic range (Ebell, 2005). Consistency of the 
INR can be found after four days (Holbrook, et al., 2012). INR therapeutic range, which 
differs from consistency, can be found in one week and also at two weeks (Ebell, 2005). 
Posttest knowledge was determined two weeks after the intervention was implemented. 
The posttest functioned as a diagnostic tool since it was able to identify the patient who 
did not have knowledge of OAT (Speros, 2009). The post-test showed information the 
patient had learned or information the patient already knew (Speros, 2009). It also 
identified the topics the patient did not know and evaluated the topics the patient had not 
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learned (Speros, 2009). More effective teaching assisted the patient on OAT through 
Roy’s adaptive process.  
 Teaching about OAT therapy is generally done and documented when the 
patient begins the medication. Whether the patient has taken OAT or is new to OAT, the 
pretest provided an evaluation of the patient’s current knowledge. The OAT pictorial 
booklet Blood Thinner Pills: Your Guide to Using Them Safely (Huber, 2005) as well as 
the educational intervention promoted patient recognition of coordinating a healthy 
lifestyle with medication. The booklet and intervention indicated OAT therapy as being 
critically important to the patient’s care, as well as fostered the patient’s personal 
understanding of their OAT.  
 Roy stressed that adaptation is a continuum (Phillips, 2010). The APN should 
therefore examine the adaptation continuum for patients on OAT. Various patient 
adaptations with INR values not in therapeutic range triggered the APN to begin 
investigating OAT as an EBP project. Ongoing evaluation of patients assists nursing with 
interventions to facilitate patient outcomes. Adaptation occurs after the patient displays 
an environmental response. The adaptation response may be effective or ineffective.   
Nursing has a unique goal to effectively assist the patient’s environmental adaptation 
process with the patient utilizing OAT. As nursing guides the patient on OAT to manage 
the environment, the result is an attainable goal of optimum wellness by the patient.  
 Strengths and limitations of the Roy theoretical framework for the OAT 
project. Strengths of the Roy model include its ability to be experienced by the patient 
and observed by nursing (Phillips, 2010). The Roy model is a practice theory that 
outlines nursing assessment as it relates to the patient’s self-concept (Roy, 2011). 
Nursing assessment draws conclusions about appropriate nursing interventions, 
addresses multiple patient variables, and facilitates patient adaptation (Phillips, 2010).  
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 The Roy model focuses on the patient and the patient’s adaptation (Roy, 2011).  
The patient is the active participant and the nurse is the guide (Roy, 2011).  As a 
framework, the model serves to facilitate the project manager’s thinking of patients’ 
problems of adaptation with OAT. The model can evaluate the patient’s food source 
adaptation. Roy’s model assisted the project manager to distinguish between effective 
and non-effective adaptation by patients on OAT and their families. Adaptation helped 
the patient put his or her energy into improving health. Finally, the Roy model provided a 
framework to affect knowledge development of adaptation in the patient on OAT 
(Phillips, 2010).  
 Four modes of adaptation named in the Roy model are considered a weakness 
of the model. As adaptation is considered a process, Roy’s model was weak when a 
quick decision has to be made, such as in sudden bleeding from OAT, with emergent 
treatment options (Phillips, 2010). However, the model affected knowledge development 
assisting the patient on OAT with information about problem solving, such as stopping 
the sudden bleeding and what to do for emergent treatment options. Another weakness 
of the model was implied direction for the nurse if the patient does not choose to actively 
participate in adaptation (Roy, 2011). The model was considered limited because it 
primarily addressed the concept of patient adaptation and focused on the patient (Roy, 
2011). Finally, the information on the nurse or nursing assessment and intervention was 
implied (Phillips, 2010).   
The EBP Model of Implementation 
 The Stetler model for EBP.  The EBP model for this project was the Stetler 
model. The Stetler model allows individual nurses to use critical thinking skills as well as 
evidence to implement change in daily practice pattern (Romp & Kiehl, 2009). Analyzing 
current practice patterns with opportunities to improve practice also promotes the Stetler 
model for individual use (Stetler, 2001).  
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 In addition to critical thinking and reflecting practice patterns, the Stetler model 
EBP provides the clinician with phases or steps to follow. Ciliska et al. (2011) 
summarized the order of these phases:  
 1.  Naming the clinical issue or problem 
 2.  Finding the change agent(s) who will champion the cause to facilitate a     
     change in practice  
 3.  Looking for research based on levels of evidence to support the problem  
 4.  Naming the barriers to the practice change and communicating how to  
     address the barriers 
 5. Clarifying ways to disseminate the information depicting the change in   
     practice 
 6.  Proceeding with the change in practice 
 7.  Examining the impact of the change in practice on structure, function and    
      overall outcomes 
 8.  Finding ways to keep the change in practice current and applicable  
 The Stetler model defined evidence in healthcare information that is able to be 
reproduced, observed, and remains dependable through time (Ciliska et al., 2011). In 
addition, evidence is able to be verified and supported within the literature (Stetler, 
2001). Furthermore, evidence in the Stetler model can come from a variety of resources 
(Ciliska et al., 2011). There are two types of evidence in the Stetler model (Stetler, 
2001).  Evidence may be described as external evidence (Ciliska et al., 2001). External 
evidence comes from outside research that is able to be reproduced, observed, and 
supported for practitioner use (Stetler, 2001). Internal evidence includes local facts, 
figures, quality measures, outcomes and evaluations as well as collected data (Stetler, 
2001). In addition, EBP adds patient preferences or patient wishes which adds to 
additional internal evidence (Ciliska et al., 2011).   
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 Application of the Stetler model to the OAT project. This EBP project 
included an individual patient assessment of OAT knowledge, followed by a teaching 
intervention. A second patient assessment followed in two weeks to determine the 
effectiveness of the educational intervention. Implementing the Stetler model in this 
project provided a step-by–step framework for an individual clinician to incorporate 
theory, literature, and include patient preferences to promote a change in practice.  
 The five phases of the Stetler model which facilitate EBP are (a) preparation, (b) 
validation, (c) comparative evaluation/decision making, (d) translation/application, and 
(e) evaluation. Each of these phases is discussed.   
 Phase I: Preparation. The first phase is described as a time to identify the 
problem and acknowledge any less-than-best practice relative to it. In this project, the 
clinical problem was “What were the best approaches to facilitate the adult patient who is 
using OAT and maintain the INR in therapeutic range?” As part of the preparation, 
relevant evidence was found in the literature related to the clinical problem. External 
evidence revealed patient education in a one-on-one setting, that included safety issues 
the patient could understand, written in large print with pictures that increased learning 
(Clarkesmith, Pattison, & Lane, 2013; Nasser, Mullen, & Bajorek, 2011; Wofford, Wells, 
& Singh, 2008). Literature explained that a take-home video on OAT further reinforced 
the interventions and provided periodic “refreshers” for the patient and family 
(Clarkesmith, Pattison, Lip, & Lane, 2013; Mazor et al., 2007; Nasser et al., 2011; 
Wofford et al., 2008).  Additional external evidence showed a patient questionnaire to 
evaluate learning was also a valuable tool for facilitate patient knowledge (Clarkesmith et 
al., 2013; Lane, Ponsford, Shelley, Sirpal, & Lip, 2005). Still further, external evidence 
described if patients had a poor understanding of food choices, a non-therapeutic INR 
can result (Clarkesmith, Pattison, and Lane, 2013; Wofford et al., 2008; and Cook-
Campbell & Sefton, 2010).  In addition, patients on OAT were asked their opinion why 
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the INR was unstable. This question added internal evidence. Clinic data revealed 
instances when the patient’s OAT dose was changed to achieve the therapeutic INR, but 
not accomplishing a therapeutic INR provided additional internal evidence. Other clinic 
patients on OAT had a therapeutic INR dosing regimen but failed to maintain it. Finally, 
groundwork for project resources within the clinical agency as well as project time 
frames were deliberated during the preparation phase.  
 Phase II: Validation. In the second phase, evidence in the literature related to 
the clinical question was reviewed and analyzed for its validity, reliability, and 
applicability to the clinical question (Melnyk & Fineout-Overholt, 2011). Literature was 
evaluated according to the level of evidence table from Melnyk and Fineout-Overholt 
(2011) rating system for the hierarchy of evidence. The rating system for the literature 
pertaining to the clinical question was located in systematic reviews, randomized control 
trials (RCT’s), and additional levels of evidence. All levels of evidence were ranked 
according to their quality from higher to lower levels of evidence on a validation scale. 
Non-credible resources were discarded when the level of evidence could not be 
measured, or there was no reproducible study within the literature. Stetler (2001) cited if 
no credible literature is found, the EBP project would end.  
 To conclude the validation phase, current evidence found in the literature was 
combined with clinical practice to determine the project’s purpose and measureable 
outcomes. This analysis revealed that both the literature and clinical practice drive the 
need for the project. The project becomes a priority in evidence-based clinical decision 
making for the project leader (Stetler, 2001).      
 Phase III: Comparative evaluation/decision making. Phase III began with 
making a comparative evaluation of the information already gathered and a decision 
about the project. This phase was a breakdown and compilation of Phase I and Phase II. 
The breakdown and compilation influenced decisions or recommendations which apply 
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to practice. Decisions regarding practice recommendations were incorporated in Phase 
III. The findings were a problem-solving fit and accurately reflect current practice (Stetler, 
2001).  Nasser et al. (2011) did find in their systematic review that educational 
interventions regarding OAT did make a difference and resulted in better anticoagulation 
control.  
 Phase IV:  Translation/application. The EBP was translated and applied to 
current practice in Phase IV (Romp & Keihl, 2009). In this project, the project manager 
introduced the patient on OAT to the educational intervention. The educational 
intervention focused on understanding the patient’s condition and experiences with OAT. 
Patient responses facilitated this project manager’s appreciation of why the intervention 
was important. The educational intervention augmented the interdependence between 
patient and nursing. The translation or application to practice was the consistent 
evaluation and knowledge exchange between each patient on OAT and nursing in 
primary care. Such a change in practice also facilitated the office staff understanding of 
the patient’s knowledge of OAT. The educational intervention showed itself beneficial to 
patients who have OAT prescribed for their cardiovascular conditions. Measuring the 
patient’s knowledge of OAT and implementing a teaching intervention emphasized 
patient knowledge acquisition and led to better outcomes. The outcome data were 
utilized to promote continued informative patient education. The patient assessment and 
educational intervention translated into new practice for the current primary care office.    
 Phase V: Evaluation. In Phase V, outcomes were presented with a formative 
evaluation done by the project manager on the actual implementation and goal progress 
for the practice change. In addition, Phase V included a summative evaluation of Phase I 
outcomes and goal results that reflected OAT patient outcomes. The project manager 
conducted an evaluation of all the outcomes.     
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 Identified strengths and limitations of the Stetler model for the OAT project. 
Strengths of the Stetler model included more direction for the project manager to 
examine EBP (Stetler, 2001). The OAT project had one project manager. Another 
strength detailed appropriate application of existing research-based knowledge into 
practice (Ciliska et al., 2011). For this project, literature regarding educational 
interventions in patients using OAT were located and applied to the OAT project. The 
phases of the Stetler model further helped prevent the project manager from using 
research inaccurately (Romp & Kiehl, (2009). The Stetler model supported and 
recreated critical thinking among providers who worked with the project manager. The 
project manager also utilized the model’s use of both research utilization (RU) and EBP. 
The Stetler model facilitated programs and practice methods which improved nurse 
satisfaction, increased the commitment of nurses to the practice and reduced the 
turnover rate (Romp & Kiehl, 2009).  
 A limitation of the Stetler model was found in the overlapping of phases which 
could have caused the project manager to go back to a previous phase (Stetler, 2001).  
As an example, a decision to use evidence was found in Phase III, such as whether to 
use the intervention of an individual class or group classes with OAT intervention. The 
project manager then went back to Phase II to see if the evidence applied to the project.  
As the project manager then moved forward to Phase III, the project could have stopped 
at Phase III if the strength of the decision was not sufficient to support the practice 
change (Romp & Kiehl, 2009). The project manager’s awareness of the overlapping 
phases avoided this situation. Another limitation for the project manager was in Phase 
IV, in the application of the evidence. The EBP evidence may not provide details for a 
complete procedure change, based on the different levels of evidence (Stetler, 2001). 
Strong, highly ranked evidence and current practice pattern of utilizing questionnaires 
with educational interventions with other disease processes avoided this limitation.  
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 Another limitation was in Phase IV, the evidence in the project findings implied or 
encouraged its users to fill in the blanks with their own information or judgment and 
make a conclusion (Stetler, 2001). Statistical evidence found in this project addressed 
the previous limitation. Phase IV, as an application phase, suggested the levels of 
evidence within a set of actions are reported as findings (Romp & Kiehl, 2009). This cites 
another limitation as the findings can be adapted rather than adopted into practice 
(Romp & Kiehl, 2009). Again, strong, highly ranked evidence supports an improved APN 
practice pattern.   
    Combining both the Roy model of adaptation with the Stetler model guide 
for EBP.  To combine the two theories, Roy’s Adaptation model showed patient 
adaptation to change and facilitated adaptation through nursing care. Nursing influenced 
environmental stimuli for the patient’s benefit. Patients were able to see their own 
personal dignity and self-esteem improve by being recognized first as patients on OAT. 
Confirming or increasing the patient’s knowledge base of their medical condition utilizing 
OAT increased their self-worth. The patient’s adaptation and hands-on involvement in 
their care motivated patient to focus on consistent meals, beverages and medications for 
optimal outcomes, therapeutic INR’s, and fewer adverse events.  
 The Stetler model was a framework for nursing to guide the project manager 
from research utilization to outcomes with EBP. This approach relied on internal 
evidence which was the process of gathering current patient outcomes, preferences, and 
clinical expertise (Stetler, 2001). The internal evidence combined with external evidence 
or project outcomes to facilitate EBP for the patient using OAT. Literature citing the 
problems of OAT had been found in systematic reviews, RCT’s and other levels of 
external evidence. The levels of evidence provided a framework to illustrate best 
practice. Clinic and medical center data emphasized a need to change practice.  As an 
APN, the project manager’s plan was to use both RU and EBP to plan change and 
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evaluate this change both in formative as well as summative data using the Stetler 
model (Stetler, 2001).  
 Current practice and proposed change.  As part of current practice in the 
medical center system, patients new to OAT have medication teaching done at the 
hospital or outpatient clinic setting. Patients in either setting receive A Patient’s Guide to 
using Coumadin®/Warfarin (Ludwig, 2008). This is an eight-page booklet which is given 
to patients who begin OAT in the hospital or outpatient setting. The booklet is written on 
a ninth-grade reading level and printed in 12-point font. There are no pictures in the 
booklet to facilitate patient comprehension.     
 Prescribing and dosing OAT was done by clinical practice guidelines, either by 
itself or concomitantly with antiplatelet medication such as aspirin or clopidogrel 
(Holbrook et al., 2012). For example, patients with atrial fibrillation began OAT therapy at 
either two or five milligrams daily (Ebells, 2005). Other patients utilizing OAT who had 
deep vein thrombosis (DVT) had the adjunct of injectable enoxaparin along with five 
milligrams of OAT to help them achieve therapeutic INR with a faster response. The 
patient obtained a baseline INR and complete blood count (CBC) on day one. Another 
INR and CBC were drawn in four days. A subsequent INR was drawn in seven days. 
The enoxaparin or heparin was discontinued when the INR is between 2.0 to 3.0 for DVT 
patients; the OAT was continued daily (Holbrook et al., 2012). Patients who had atrial 
fibrillation continued taking OAT daily. Patients who used multiple cardiac medications 
had their dose adjusted which influenced Vitamin K synthesis.   
 Nursing staff in primary care telephoned patients with their INR value and 
directions for the next dosing. The staff informed patients to write down directions for 
dosing. Current clinical guidelines showed INR testing to be subsequently drawn every 
one, two, three, or four weeks based on the number of consecutive in-range INR’s within 
those intervals (Ebells, 2005). An example of this was a patient who had an INR result 
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between 2.0 to 3.0. The next test was requested in one week, subsequent tests were 
requested in two weeks, then three weeks, and next in four weeks as long as results 
were within 2.0 and 3.0. There was a maximum of four weeks between INR testing 
(Ebells, 2005).  
Literature Search 
 Search engines and key words. The search for current literature pertaining to 
OAT in the primary care setting included the databases from (a) Cumulative Index to 
Nursing and Allied Health Literature (CINAHL), (b) Medline, (c) ProQuest, (d) Johanna 
Briggs Institute (JBI), (e) Cochrane Database of Systematic Reviews, (f) Nursing 
Reference Center, and (g) the National Guideline Clearinghouse. The search also 
included a hand search from available literature. In addition, one article was located 
doing a citation search from the literature references used in the levels of evidence.   
The following search terms were used: warfarin or Coumadin, oral anticoagulation 
therapy, educate, teach and train, knowledge, self-administration, and educational 
strategies. The terms were used in various combinations to obtain maximum results from 
the databases. After the initial search was completed, abstracts were reviewed after a 
hard copy of the literature was created and reviewed for correct inclusion criteria. See 
Summary of Evidence, Figure 2.1.   
 Inclusion/exclusion criteria.  Inclusion and exclusion criteria were used to 
determine the most relevant evidence as it relates to the PICOT question. Inclusion 
criteria limiters included (a) published literature in the English language, (b) involved 
adult populations of age 45 through over 80 years of age, and (c) dated from January, 
2005 through July, 2013. The inclusion criteria were chosen based on the characteristics 
of the population for the project. Further analysis of inclusion criteria examined improving 
clinical outcomes through education and educational interventions for stable 
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maintenance dosing of OAT.  Additional criteria included literature noting challenges in 
the patient’s knowledge of OAT.  
 Exclusion criteria established were articles published prior to 2005 and those that 
did not include the search terms of warfarin or Coumadin, oral anticoagulation therapy, 
educate, teach and train, knowledge, self-administration, and educational strategies.   
Exclusion criteria also included literature of patients on OAT who were self-managed, 
that is, patients who dosed their own OAT at home with prompt directions. Literature 
entirely based on patients who were cared for by stand-alone OAT clinics without 
hospital affiliation was also omitted. Children and adolescents were omitted from 
inclusion criteria as well as long-term care patients who did not dose their own 
medications. Published works describing best control practices of OAT but not including 
any education in OAT were also deleted. Literature on educational interventions solely 
for hospitalized patients on OAT was discarded. However, educational opportunities 
comparing post-hospitalized patients continuing outpatient educational interventions 
were included. Literature was examined and considered based on evidence-based 
practice, clinical guidelines, systematic reviews, qualitative or quantitative studies, and 
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Figure 2.1  
Summary of Evidence 
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 Summary of evidence.  See Figure 2.1. The initial search of CINAHL found 32 
hits, 18 articles were located by title, and 14 articles were initially reviewed by abstract. 
Full text review was completed on 12 articles. This resulted in one article which met 
inclusion criteria in the analysis. The one article consisted of one well-designed RCT.  
 The Medline database first located 80 hits and 47 articles by title. Of these 
articles, 18 were initially reviewed by title and abstract, and three were duplicates from 
the CINAHL database. Medline full text review was completed with 15 articles, with four 
of them included in the analysis. The four Medline articles included one RCT, and three 
were single descriptive studies.  
 Johanna Briggs Institute database yielded two hits and two articles were found 
by title. These two articles were initially reviewed by abstract, but neither article met 
inclusion criteria.   
 The Cochrane database found 31 hits and 31 articles by title. There were four 
articles initially reviewed by abstract. Full text review was completed on two articles. The 
one article included in the analysis was a systematic review.       
 ProQuest yielded nine hits and one article was located by title and abstract. 
However, this article did not meet inclusion criteria and was not in full text review.     
 Nursing Reference Center’s database found 258 hits, with 168 articles located by 
title, and 30 were initially reviewed by abstract. There were six duplicates located in the 
CINAHL, Medline, and Nursing Reference Center databases. Full text was reviewed in 
eight articles. The one article included in the analysis was a systematic review which met 
inclusion criteria. 
 The National Guideline Clearinghouse was searched as well. There were 48 hits 
with 48 clinical guidelines found by title; two met initial review by abstract. One clinical 
guideline for OAT was selected. The second clinical guideline on OAT was not selected 
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as these were clinical guidelines for Great Britain and did not list the same INR 
therapeutic range as the United States. 
  A hand search of the literature was also performed for the project. There were 
1040 articles located, adding the search term educational strategies narrowed the 
articles to 32 articles that were initially reviewed by title. The articles which were 
reviewed by abstract included five duplicates in CINAHL, Medline, and Nursing 
Reference Center databases. Full text review was done on 26 articles and two articles 
were selected for the project. The literature selected was one systematic review and one 
cohort study based on inclusion criteria.   
 A citation search was done over the previously selected articles for the project. 
One article was selected based on inclusion criteria and this was a single descriptive 
study. A second literature search was done over all the data bases previously listed. 
There were no additional articles retrieved.   
 All literature included in the summary of evidence on OAT was reviewed for level 
of evidence, sample size, method of evaluation of the evidence, conclusions drawn from 
the evidence, and number of sites used. The 11 pieces of evidence yielded by the 
literature search provide the framework for the interventions listed in this EBP project.  
Levels of evidence. Levels of evidence for this project were evaluated by the 
rating system for the hierarchy of evidence for intervention/treatment questions by 
Melnyk and Fineout-Overholt (2011).  Level I evidence is evidence from a systematic 
review or meta-analysis of all relevant RCT’s and is considered the highest level of 
evidence on this scale. Level II evidence is retrieved from well-designed RCT’s. Level III 
is evidence from well-designed control trials that do not have randomizations. Level IV is 
evidence from well-designed cohort or case-control studies that are well designed. 
Evidence found in Level V comes from systematic reviews of descriptive and qualitative 
studies. Level VI is evidence from single descriptive or qualitative studies. Level VII is 
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evidence from expert committees or opinions of authorities (Melnyk and Fineout-
Overholt, 2011).   
 There were three systematic reviews of Level I evidence and one clinical 
guideline of Level I evidence found for this project. Level II evidence located for this 
project was two randomized control trials. There was no Level III evidence found. Level 
IV evidence included one case-control article. There was no Level V evidence located 
for this project. Level VI evidence was found in four articles. No Level VII evidence was 
found for this project.  
Evidence Appraisal 
 Specific questions related to critical appraisal were used from Critical Appraisal 
Skills Programme (CASP) (2014). Evidence studies were chosen for their validity, 
reliability, and applicability to the project and to answer the clinical question. The 
literature in the review was all evaluated by the CASP method. Rating scale for the 
literature was scored with a threshold of 7 out of 10 detailed points for validity, reliability, 
and applicability in the CASP rating scale to be considered for this project.  The AGREE 
II tool was used to score the clinical guidelines. 
 Level I evidence. Clarkesmith, Pattison, and Lane (2013) provided a systematic 
review of eight trials with a total of 1,215 patients with atrial fibrillation (AF). The authors 
showed a specific population of newly diagnosed patients with atrial fibrillation to those 
with permanent AF and accepted as the normal heart rhythm. RCT’s of educational or 
behavioral interventions with any length of follow-up were studied. Any language was 
included in these trials which were held in six different countries. Databases searched 
included Cochrane, Medline, EMBASE, and CINAHL.   
 Educational interventions included educational booklets, videos, decision aids, 
and talking interventions. The studies also included behavioral interventions designed to 
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modify the patients’ response toward treatment and symptoms. These interventions 
included cognitive behavioral therapy, motivational interviewing, and biofeedback. 
It was reasonable to combine the reviews as the primary outcome measure was the 
percentage of time spent within therapeutic range. Overall results did not favor self-
monitoring plus education in improving time in therapeutic range, with a mean difference 
of 6.31 (95% CI -5.63 to 18.25). Secondary outcomes measured were increased 
knowledge with regard to AF and anticoagulation therapy, patient satisfaction, and 
acceptability of OAT. Secondary outcomes also included quality of life, changes in 
perception toward AF and INR control. Additional secondary outcomes included changes 
in the patient’s illness beliefs and illness representations. Further secondary outcomes 
included self-reported adherence to treatment, cost-effectiveness of the intervention, and 
a change in the patient’s beliefs about medications. Secondary outcomes favored usual 
care over decision aids for reducing decision conflict, with a mean difference of -0.1 
(95% CI -0.2 to -0.02).  
 These outcomes applied to the population in this project as those who self-
monitor (but not self-dose) do not have any more time in therapeutic range than those 
patients who have laboratory testing. Also, patients in usual care (no education but initial 
instruction when warfarin initiated) reflect the project population with their INR stability 
versus patients who have decision aids from another healthcare source and have INR 
instability. An outcome not considered in this article was the psychological impact for the 
patient. Although the researchers concluded that more trials are needed to impact 
education and behaviors of the patient on OAT, the benefits outweigh the harm and cost 
due to the secondary outcomes noted. This Level I evidence received a CASP score of 
nine.      
 Nasser et al. (2011) reviewed 62 articles and focused on the challenges for 
adults over 65 years for patient knowledge of OAT, access to OAT education, and 
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educational resources. Their literature review was done in Medline, EMBASE, CINAHL, 
International Pharmaceutical Abstracts, Meditext, and Google Scholar. The researchers 
compiled a comprehensive literature search over a 20-year time span. However, the 
literature retrieved was only in English. Results of the studies were reasonable to 
combine as their primary endpoints included improved knowledge in older patients 
improved their anticoagulation control. Overall results of the studies were expressed by 
statistical significance.  
 The researchers noted that between 50-80% of older patients had inadequate 
knowledge about basic aspects of warfarin therapy. These knowledge deficits included 
OAT’s action, benefits and risks, and interactions with food or drugs. Demographic 
factors such as advancing age, lower family income, and limited health literacy were 
found to inversely affect patients’ warfarin knowledge. In addition, access to warfarin 
education was often suboptimal in different practice settings. Major barriers to patient 
education included lack of provider time to teach as well as a lack of a multidisciplinary 
approach to teaching in busy outpatient healthcare settings. Educational strategies and 
resources such as providing the patient with information at their cognitive skill level, 
videos for home use, and group classes improved outcomes. Providing individual 
classes for patients as well as including a patient knowledge assessment of OAT 
improved outcomes. All important outcomes were considered as the educational 
knowledge testing also assisted with cognitive assessment. The Nasser et al. (2011) 
Level I evidence received a CASP score of nine.    
 The populations and outcomes discussed by Nasser et al. (2011) were applied to 
the OAT project.  The adult patients on OAT in this project with multiple comorbidities 
were reflective of the Nasser et al. (2011) study. It was estimated that 40 patients in the 
project population had inadequate knowledge of foods, beverages and other medication 
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interaction with OAT.  A knowledge assessment was done with the project population 
that determines their learning needs and what the patients learned. 
 Holbrook et al. (2012) provided a set of 2012 clinical practice guidelines for 
patients on OAT in a rigorous review. Melnyk and Fineout-Overholt (2011) noted that 
clinical guidelines are specific practice recommendations resulting from rigorous reviews 
of the best evidence on the topic and therefore are Level I evidence. Guidelines provide 
answers for clinical practice. Guidelines function as tools to improve the quality and 
process of care. In addition, the guidelines also function to improve patient outcomes, 
reduce the variation in care, and help avoid unnecessary expenditures (Melnyk & 
Fineout-Overholt, 2011).   
 The 2012 clinical guidelines from the American College of Chest Physicians 
specifically addressed evidence-based management of anticoagulant therapy (Holbrook 
et al., 2012). The focus of these guidelines is antithrombotic therapy and prevention of 
thrombosis. The guidelines are in its ninth edition and replaced a previous version from 
2008. The American College of Chest Physicians evidence-based clinical practice 
guidelines include 216 references. Guideline objectives were to (a) update EBP 
recommendations for the use of anticoagulant therapy for the management of 
thromboembolic conditions, (b) offer guidance for many common problems related to 
OAT, and (c) optimize patient health outcomes and the processes of care for patients 
who have experienced or are at risk for thrombotic events (Holbrook et al., 2012).  
 Evidence for the clinical practice guidelines for this study was selected from 
systematic reviews and randomized control trials. Observational studies were also 
included where there was insufficient RCT data addressing an intervention and for 
questions of risk assessment. The guidelines focused on vitamin K antagonists 
(warfarin/Coumadin®) and unfractionated heparin or low-molecular-weight heparin 
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(LMWH) such as injectable enoxaparin sodium (Lovenox), which is available in the 
United States.   
 The clinical guidelines were analyzed on an outcome basis using criteria from the 
Grading of Recommendations Assessment, Development, and Evaluation (GRADE) 
approach to rating quality of the evidence. Expert consensus was the method used to 
formulate the recommendations (Holbrook et al., 2012). The rating scheme for the 
strength of the recommendations ranged from strong recommendation, high quality 
evidence, Grade 1A to weak recommendation, low quality evidence, and a grade of 2C.  
There were six grades of recommendation in all. All grades included RCT’s and 
observational studies. Implications for patients were given for each grade of 
recommendations.  
 The AGREE II instrument (Appraisal of Guidelines for Research & Evaluation II) 
(Brouwers et al., 2010) was also used to evaluate the set of clinical guidelines of 
Holbrook et al. (2012) (Level I evidence). The AGREE II 23-item evaluation tool 
measures six domains for quality in order to guard against potential biases of guideline 
development. The recommendations were also considered internally and externally valid 
and were usable for practice. Scoring is from 1 of strongly disagree through 7, strongly 
agree.  
 The first domain explained the scope and purpose for quality of the guideline. 
The overall objectives of the guideline are specifically described and found in guideline 
objectives and target population Agree Score: 7 (AS: 7).The health questions covered by 
the guideline were specifically described (AS: 6) as well as the population for whom the 
guideline was intended (AS: 7) and found in the target population section.  
 Stakeholder involvement was the focus of the second domain. All committee 
members were medical doctors or doctors of philosophy (AS: 4).Other stakeholder views 
and preferences from the target population, such as the patients who were sought but 
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not clarified in the guidelines (AS: 1). Target uses of the guidelines were clearly defined 
and listed under intended users for OAT (AS: 7).  
 The rigor of development was completed systematically and found under the 
description of methods used to collect/select the evidence (AS: 7).  In rigor of 
development, the criteria for selecting the evidence were clearly described and found in 
defining the clinical questions of population, intervention, comparator, and outcome (AS: 
7).  The strength and limitations of the body of evidence were clearly described and 
found in assessing studies and summarizing evidence (AS: 7). The methods for 
formulating the recommendations were clearly described. The group met as a 
Consensus Development Conference (AS: 7). The health benefits, side effects, and risks 
considered in formulating the recommendations was done by using the GRADE rating 
scale mentioned previously (AS:6). There was an explicit link between the 
recommendations and the supporting evidence to ensure consistency across articles 
(AS: 6). Clinical guidelines have been externally reviewed by experts prior to its 
publication and located in method of guideline validation (AS: 6). Updating the guideline 
procedures were not provided (AS: 1). 
 Guidelines were clear in language, structure and format; the recommendations 
were specific and unambiguous (AS: 7). Clinical guidelines for different options in 
management of OAT (AS: 7) as well as key recommendations were easily identifiable 
and located in recommendations (AS: 7). 
 For applicability of presentation, the guidelines described facilitators and barriers 
to its application and improvement. These methods of improvement were located in the 
guideline recommendation section describing the benefits/harms of implementation (AS: 
7).The guideline provided advice and/or tools placing the recommendations into practice. 
Advice was found in evidence supporting the recommendations (AS: 7). Potential 
resource implications of applying the recommendations were considered and found in 
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the benefits/harms section of implementing the guideline recommendations (AS: 6). 
Clinical guidelines presented monitoring and/or auditing criteria and this criteria was 
found in qualifying statements (AS: 7).   
 Under editorial independence, the views of the funding body did not influence the 
content of the guidelines and listed under source of funding (AS: 5).The final criteria 
asked for competing interests of guideline development. There was a complete listing of 
group members with their financial disclosures and conflicts of interest. (AS: 7). 
 Applying the AGREE II evaluation tool (Brouwers et al., 2010) to this EBP project 
resulted in a total score was 139 out of 161. The CASP score was nine. These scores 
were found to be acceptable for the project.    
 Wofford, Wells, and Singh (2008) identified best strategies for patient education 
about OAT in a systematic review. The researchers’ background noted teaching OAT is 
often ignored since it is time consuming for clinicians and overwhelming for patients. To 
identify the best education strategies, the Wofford et al. (2008) initial search of 206 
citations decreased to 32 for data extraction in Medline and Google Scholar and was 
found only in English. Authors searched literature matching their population based on 
clinical setting, study design, group size, personnel involved, educational strategy, and 
patient’s knowledge retention. Results of the reviews were not listed numerically but 
given in priority for topics required for knowledge of OAT as well as the assessment 
tools available to measure patient knowledge. Delivery of the content of OAT was 
reinforced with handouts and videos to use at home for “refreshers”. Outpatient clinic 
setting and size applied to the project on OAT this systematic review, as well as 
prioritizing patient topics and the need to measure outcomes with a validated instrument. 
The CASP score was seven.    
 Level II evidence. Mazor, et al. (2007) reported on three approaches to 
communicating with patients about safe warfarin use. The approaches in this 
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randomized clinical trial included patient education incorporating narrative evidence such 
as patient anecdotes, statistical evidence, and narrative and statistical evidence 
combined. These three approaches were compared to a usual-care control group. 
Patients received a baseline questionnaire. Three weeks after the baseline 
questionnaire was received, a second set of study materials was sent, including a video 
on all three approaches. The control group did not receive a video. The posttest was 
included for all groups. Six hundred patients met inclusion criteria and were randomized 
in a Massachusetts anticoagulation clinic by clinic staff. Groups were similar at the start 
of the trial. There was no blinding to randomization. A total of 317 completed the study. 
Patients randomized to video intervention versus control did not differ significantly with 
respect to variables. Comparison of scores on baseline knowledge and beliefs did not 
vary between groups. The group who watched the video showed higher scores with 
increased knowledge than the control group (p < .001). This group also showed higher 
scores in the knowledge of laboratory testing (p = .010). In addition, this video-viewing 
group better understood taking OAT was beneficial (p = .012). Baseline knowledge used 
as a covariate showed patients who saw a video plus had a narrative showed greater 
knowledge gains (p = .006). The groups which were sent information of patient 
anecdotes and video instruction were found to be the most effective in patient education.   
 Results from Mazor et al. (2007) can be related to the pre- and posttest 
questionnaire. The questionnaire provided an assessment for the population as well as 
providing a narrative during the patient intervention. The RCT also included the 
individual patient’s warfarin-related beliefs regarding benefits, worry, dosing confusion or 
difficulty, and importance of testing on the questionnaire as a section of reported 
outcomes. Benefits were worth the RCT related to patients’ behavior changes from 
improved patient knowledge. The Mazor et al. (2007) RCT received a CASP score of 
nine.     
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 Clarkesmith, Pattison, Lip, and Lane (2013) discussed the TREAT (Trial of an 
Educational Intervention on patients’ knowledge of Atrial fibrillation and anticoagulant 
therapy, INR control, and outcome of Treatment with warfarin) study. The researchers 
hypothesized that poor patient understanding of atrial fibrillation and the medications to 
help avoid cardiovascular complications may add to the patients’ unwillingness to 
comply with OAT.  Patients were randomized with published registered protocol in 
Current Control Trials. Groups were similar at the start and end of the trial with a total of 
97 patients participated in the study. There were 46 who were randomized in the 
intervention group and 51 who were in the usual care group.  The patients were stratified 
as to age, sex, and location of recruitment in two locations in Birmingham, United 
Kingdom. The patient intervention was a DVD program, handout, self-monitoring diary, 
and worksheet. The usual care group received the same handout only. The patients 
were followed at intervals of one, two, six, and twelve months.    
 The primary endpoint was time in therapeutic range. The intervention group had 
significantly higher time in therapeutic range than the usual care group at six months 
(76.2% vs. 71.3%; p = 0.035). Surprisingly, at 12 months the differences were not 
significant (76.0% vs. 70.0%; p = 0.44). Secondary endpoints were knowledge, quality of 
life, depression, and anxiety. Medication beliefs such as considering OAT harmful and 
the patients’ understanding of their cardiovascular condition were also secondary 
endpoints. Knowledge was found to increase over time (p = 0.01) but there was no 
difference between the two groups (p = 0.07). Knowledge scores predicted time in 
therapeutic range at six months after the intervention. The differences in knowledge 
scores were not significant at 12 months. The authors believed these results 
demonstrated that the intervention allowed the patient time to make behavioral changes 
and implement the changes to maintain their INR over time. Since the authors found the 
THE EFFECT OF AN EDUCATIONAL INTERVENTION ON OAT                          42 
 
intervention did not result in statistically significant differences at the 12-month interval, 
they concluded that a periodic intervention be implemented to help maintain adherence.  
 Clarkesmith, Pattison, Lip, and Lane (2013) concluded that an educational 
intervention improved time in therapeutic range by atrial fibrillation patients using OAT 
during the first six months after the intervention. The authors added that adverse 
outcomes may be decreased by improving the patients’ knowledge and comprehension 
of OAT. Finally, the authors concluded education for patients with atrial fibrillation is 
necessary for effective dosing and patient safety. The TREAT RCT can be applied to the 
OAT project as it used a questionnaire to determine patient knowledge of OAT. The 
TREAT RCT also utilized an educational intervention with a pictorial booklet and video to 
improve the patient’s lack of knowledge as well as to address barriers to treatment and 
compliance.  CASP score for the RCT was nine.    
 There was no Level III evidence located for this project.     
 Level IV evidence.  Pernod, Labarere, and Bosson (2008) evaluated the effect 
of an oral anticoagulation program to improve knowledge and reduce complications from 
both bleeding and clotting. There were a total of 302 patients, 135 women and 167 men 
who were randomized among 15 physician practices and 26 hospital departments in 
Grenoble, France, over 24 months. The cohort was representative of the population 
representing diagnosis of deep vein thrombosis or pulmonary embolism diagnosed by 
radiography from the physician groups in private practices and hospital departments. 
The patients were randomized with a one-to-one ratio to either the control or 
experimental group by inpatient or outpatient, annual volume of patients, and surgical 
versus medical specialty for hospital departments. The study group received a one-on-
one tailored educational intervention of an approximately 30-minute teaching session. 
Each patient received a picture book describing the disease and treatment according to 
the patient’s cognitive level. The control group received the usual unstructured 
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information about Vitamin K antagonist therapy and a standard teaching booklet 
published by the French Heart Association. Both groups were assessed after three 
months with a standardized 18-item questionnaire which addressed Vitamin K 
antagonist therapy, optimal therapeutic range, and practical management of bleeding or 
non-therapeutic INR. The questionnaire was objectively scored from zero to 20 and p 
values of less than 0.05 were considered statistically significant. The mean knowledge 
score was higher in the experimental group (13.9 +/- 4.5) than in the control group (12.4 
+/- 4.9), p = 0.08). Knowledge scores were higher in younger patients under age 70 
(14.3 +/- 4.6 versus 11.2 +/- 4.4; p < 0.01) than those who were over 70 years. Patients 
who graduated from high school had a higher knowledge score than those who did not 
graduate from high school which was statistically significant (15.4 +/- 3.7 versus 11.5 +/- 
4.5, p < 0.01).   
 Another objective outcome during the three month follow-up was that the main 
criteria outcome of bleeding events was observed 15 times in the control group (10.6% 
of the patients) and 5 (3.1%) times in the experimental group. The cumulative risk 
reduction in the experimental group was statistically significant (OR 0.25%, 95% CI 0.1-
0.7, p < 0.01). The researchers objectively reported the educational program helped 
patients demonstrate a better knowledge of OAT as well as decrease the incidence of 
adverse bleeding by threefold in the experimental group compared to the control group 
(Pernod et al., 2008). Since the researchers focused on the reduction of adverse events 
of clotting or bleeding, they did not control how effective the educational program was 
based on the patient’s INR control. This may be a bias because more frequent INR 
reports were associated with fewer adverse events of bleeding (Pernod et al., 2008).    
This case control study supported the project with its educational intervention and 
knowledge of INR testing. It was given as CASP score of nine.  
 There was no Level V evidence located for this project.  
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 Level VI evidence.  Cook-Campbell and Sefton (2010) examined outpatients on 
OAT with a telephone survey of homecare patients to determine the level of knowledge 
regarding the patient’s management of OAT. The researchers found basic knowledge of 
food and medication interactions significantly decreased the adverse events of bleeding 
or clot formation.  A total of 36 patients qualified for the study based on inclusion criteria 
of no cognitive limitations and access to a telephone. Additional inclusion criteria 
included speaking and understanding English, management of their own medications, 
and the use of long-standing anticoagulation therapy of three months or longer. Content 
validity was supported through a panel of nurses and pharmacists. The questionnaire 
was given a pilot test by four rehabilitation patients following those patients’ education of 
OAT. Questions were validated by a certified gerontological nurse. Reliability of the 
survey was conducted by five patients currently using OAT in a test/retest method that 
was found to be 91% in agreement. Data collection was done by the home care nurse 
within two weeks of hospital discharge.  
 Percentages of correct responses of the 14 individual survey questions were 
described by the researchers. The question with the most correct responses pertained to 
knowledge for rationale for warfarin therapies with 94% correct (Cook-Campbell & 
Sefton, 2010). The least correct response was the question about using the Medic-Alert 
bracelet or identification cards with 28% correct (Cook-Campbell & Sefton, 2010).  
 Results answered the research question. A t test of p =.01 was significant for 
patient’s knowing one food type containing Vitamin K, t (33.1) = -2.98.  Knowledge of 
foods to be aware of interaction showed significance at p < .01, t (34) = -2.77. 
Identification of three foods high in Vitamin K was found significant between men and 
women of p <.05, t (34) = -2.16.  The term blood thinner knowledge was found significant 
at p < .10, t (19) = 1.83.  The knowledge of complication awareness was found 
significant between men and women at p < .10, t (33.6) = 1.87. Over-the-counter 
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medication interaction knowledge of patients in this group was found significant at p < 
.10, t (33.6) = -1.88.  Limitations of the study were the small sample size of 36 patients. 
In addition, the education of OAT was not given by any consistent providers but 
conducted by nurses, pharmacists, and physicians.   
 Survey questions revealed the overall knowledge about warfarin was poor, with a 
mean score of 56%. The majority of the participants were adults aged 81 or older (n = 
20). Registered nurses provided patient education on OAT during the first 24 months of 
therapy. Based upon their findings, the researchers concluded there is value to a 
comprehensive education program which follows patients across the continuum of care.  
The authors further indicated an education program with a questionnaire to document 
knowledge would also validate whether or not the patient understood the teaching and 
be able to safely manage their warfarin.  
 Findings from Campbell and Sefton (2010) study transferred well to the project 
on OAT. The age of the patients, size of the sample, a lower literacy teaching 
intervention, a 14-item survey, and patient diagnosis for OAT were all similar 
characteristics to the project on OAT. The CASP score for the knowledge retention 
home care survey was 10.  
 Smith et al. (2010) surveyed 100 patients on OAT and measured their 
Congestive Heart Failure, Hypertension, Age, Diabetes and Stroke, second revision 
(CHADS2) score. The targeted age group was 68 +/- 10 years.  A 52-item questionnaire 
was given to each of the 100 CHADS2 patients on OAT. Sampling strategies were 
clearly defined and justified as data were stratified by educational level, CHADS2 score, 
and duration of warfarin use. Comparisons between groups were based on a two-
sample t test. Group comparisons were based on Fisher’s exact test and p < 0.05 was 
considered significant.   
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 Survey questions were compiled based on the five categories of general warfarin 
knowledge, compliance, drug interactions, herbal and vitamin interactions, and diet.  
Warfarin knowledge stratified by duration of warfarin use showed none were statistically 
significant. The group using warfarin greater than five  years had a higher score for more 
knowledge but was not statistically significant (p = 0.281). The group using warfarin less 
than one year showed more compliance but was not statistically significant (p = .453). 
There was essentially no statistically significant difference in the three groups showing 
knowledge in drug-drug interactions (p = 0.869). There was no statistically significant 
difference in the three groups’ knowledge of drug-vitamin supplement knowledge (p = 
0.148). The group using warfarin over five years showed more knowledge of diet, but it 
was not statistically significant (p = 0.686).   
 Warfarin knowledge was also stratified by CHADS2 score. General knowledge (p 
= 0.301) and compliance (p = 0.1777) were not found to be statistically significant among 
the three groups. Drug-drug interaction knowledge was not found statistically significant 
among the three groups (p = 0.329), nor was drug-vitamin supplement knowledge (p = 
0.366). In addition, diet knowledge was not found statistically significant among the 
groups (p = 0.534).  
 The researchers worked to understand how educational levels influenced survey 
scores favorably or unfavorably. There were no significant differences between groups in 
any category with respect to maximum educational level achieved or duration of therapy.  
Results also reflected knowledge of CHADS2 risk scores. Patients with higher CHADS2 
scores had no significant difference in their knowledge, compliance, drug-drug 
interactions, or drug-vitamin supplement knowledge, but did score higher on their 
knowledge of diet. There was also no significant difference in knowledge for patients on 
OAT under 75 years versus those over 75 years.  
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 The researchers concluded the negative impact that knowledge deficit has on 
warfarin therapy. They concluded that drug education, if provided at all, is often 
delivered at the beginning of therapy. The researchers emphasized the need for ongoing 
knowledge assessment with educational approaches to improve patient outcomes.  
 Results can be transferred to the project on OAT. The subjects in the Smith et al. 
(2010) study were similar to the population for the project on OAT related to their age 
and educational levels. Scores for the project on OAT showed patients at highest risk 
score the lowest in knowledge of OAT. Researchers in the Smith et al. (2010) study 
noted the negative impact of the knowledge deficit of OAT and the potential for 
educational strategies to improve treatment outcomes as well as effectiveness of OAT. 
The educational strategies, improved treatment outcomes, and effectiveness of OAT 
were all parts of this project on OAT. The CASP score was seven.       
 Lane, Ponsford, Shelley, Sirpal, and Lip (2005) studied patients with atrial 
fibrillation using OAT in the United Kingdom. The study was designed to test patient 
knowledge of OAT and atrial fibrillation both before and after an educational intervention.  
The sample consisted of 93 patients who finished a questionnaire to determine their 
knowledge of atrial fibrillation (AF) and its multiple treatment options related to OAT. All 
the patients were given an informational booklet explaining atrial fibrillation. The booklet 
contained information about the symptoms, causes and side effects, treatment 
possibilities, and the risks and benefits of atrial fibrillation. A follow-up questionnaire was 
completed by 33 of the 93 original patients to reassess their knowledge of atrial 
fibrillation and OAT. At baseline, only 49% of the original 93 patients could name their 
heart condition. Half the patients were aware of the risk of embolism. After the 
educational intervention, there was a non-significant increase in patient knowledge of the 
risks of atrial fibrillation. In patients who completed both questionnaires, just over half 
(52% or 18 patients) understood that anticoagulants reduce blood clots. This increased 
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to 70% or 26 patients after the intervention. The educational intervention also improved 
the patient’s knowledge of INR and factors affecting INR. The researchers concluded 
that patients with atrial fibrillation may have little knowledge of their heart conditions and 
OAT. The authors also noted that a brief educational intervention utilizing an information 
booklet can help the patient’s basic knowledge about OAT used to treat atrial fibrillation.   
 Data were analyzed by 2-tailed statistical testing. Results addressed the 
research question; however, there may have been selection bias as the researchers 
stated that those who attend their appointments may be more educated about their 
underlying condition, that of AF. CASP score for the Lane et al. (2006) educational 
intervention with questionnaire research study was nine.   
 The study by Lane et al. (2006) corresponds well to the project on OAT as 
information regarding cardiovascular conditions was included in the educational 
intervention. Knowledge of the INR as well as the questionnaire supplemented the 
intervention.   
 Hu et al. (2006) conducted a cross-sectional observational study with 100 
patients who had mechanical heart valves and life-long OAT. The researchers surveyed 
100 patients over 13 months in a cardiac network database in Toronto, Ontario, with a 
validated Knowledge Information Profile (Wilson et al., 2003), a 20-item questionnaire 
used to measure the patients’ knowledge of warfarin, its side effects, and vitamin K food 
sources. This was the same questionnaire the OAT study used, before the KIP-C 
(Nordstrom et al., 2009) was reduced to 14 questions to lower the literacy level of the 
questionnaire. Results of the KIP showed 61% of the patients had scores showing 
insufficient knowledge of warfarin therapy (score </= 80%). Age was negatively related 
to warfarin knowledge score (r = 0.27, p = .007). Community counseling on OAT was 
done and included a brochure written by a pharmaceutical company. Patients with family 
incomes greater than $25,000, who had greater than an eighth grade education, and 
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who were employed or self-employed had higher warfarin knowledge scores (p =0.007, 
p = .002, and p = .001, respectively). Gender, ethnicity, and warfarin therapy before 
mechanical heart valve surgery were not related to warfarin knowledge scores.  
 Results of the Hu et al. (2006) study addressed their research question, which 
were factors influencing patient knowledge of warfarin therapy after mechanical valve 
replacement. Multivariate regression analysis showed understanding the concept of INR, 
knowing what INR means, age, and receiving the patient education were the strongest 
predictors of warfarin knowledge. Having community counseling resulted in significantly 
improved warfarin scores.  
 The Hu et al. (2006) study transferred well to the project on OAT. The same 
Knowledge Information Profile questionnaire was used, with six questions omitted to 
lower the literacy level of the questionnaire. In addition, patient education on OAT in the 
community as well as addressing demographic variables of the patient on OAT made 
this study similar to the clinical agency of the project on OAT. The Hu et al. (2006) study 






















Levels of Evidence from the Appraisal of Literature 
 
Author, Year, Study 
Design, Level of Evidence  
Sample/Intervention/Findings Strengths /Weaknesses 





Level I   
8 trials with 1,215 patients in 6 countries, interventions 
impact more time in therapeutic range, using 
educational booklets, videos, decision aids, patient 
teaching, and questionnaires.   
 
2 trials reported impact on patient knowledge, but this 
returned to pre-intervention levels after 6 months. 
 
2 trials reported improved impact on patient 
knowledge but returned to pre-intervention level after 
3 months. 
 
2 trials did not find self-monitoring plus usual care or 
education improved time in therapeutic range. There 
was a mean difference of 6.31 (95% CI -5.63 to 
18.25). The secondary outcome of patients having a 
conflict with their decision-making favored usual care 
over decision aids. The mean difference was 0.1 (95% 
CI -0.2 to -0.02). 
 
Strengths included a trial in patient satisfaction, 
education improving INR over 3 months, and 
percentage of time in therapeutic range 
improved.  
 
Weaknesses included 4 trials had mixed 
indication cohorts as patients have different 
INR ranges with valve replacements, 5 studies 
did not report the patient’s level of education 













Levels of Evidence from the Appraisal of Literature 
 
Author, Year, Study 
Design, Level of Evidence  
Sample/ Intervention/Findings  Strengths and Weaknesses  




Level I  
14,541 older adult patients using OAT 
 
50-80% of older adults have inadequate knowledge of 
anticoagulation.  
 
Assessment instruments or questionnaires were used 
to measure knowledge. 
 
Face-to-face, group sessions, written educational 
resources and videos on OAT improved patient 
knowledge and time in therapeutic range. 
Strengths: Study found improved patient 
knowledge resulted in better anticoagulation 
control. 
 
Mean knowledge scores were higher in face-to-
face group than control (p = 0.08). 
 
Statistically significant (p < 0.01) cumulative 
risk reduction in major bleeding events 
 
Weaknesses: assessment instruments or 
questionnaires were not validated; lacked 

















Levels of Evidence from the Appraisal of Literature 
 
Author, Year, Study 
Design, Level of Evidence  
Sample/ Intervention/Findings  Strengths and Weaknesses  






Level I  
The 2012 American College of Chest Physicians, 9th 
edition 
 
13 management criteria including patient education, 
used for adult patients  
 
Relevant evidence was found in systematic reviews, 
RCT’s, and prospective cohort studies. 
 
137 members were in the American College of 
Chest Physician’s Antithrombotic Therapy and 
Prevention of Thrombosis Panel  
 
Strengths: Guidelines given for warfarin as the 
oral anticoagulant 
 
Guideline authors graded the evidence through 
GRADE work group for strength of evidence, 
gave disclosure by name of entire review panel 
 
Weaknesses: No specific patient resources were 
listed for teaching; no tools were listed for patient 
assessment of knowledge.  




Level I  
32 articles related to OAT vary in strategy, patient 
testing via questionnaires for adult patients.   
 
Prioritizing educational domains, standardizing 
patient content and consistency of delivering the 
content efficiently will be necessary to improve the 






Strengths: 13 articles discuss specific 
educational strategies, such as 1-on-1 classes 
with handouts.  
 
12 articles address main objectives of the 
educational content.  
 
Weaknesses: no direction to determine the 
patient’s literacy level in the questionnaires listed 
 
No specific guidance given as what patient 
education handout to use for content or literacy 
level. 
 




Levels of Evidence from the Appraisal of Literature 
 
Author, Year, Study 
Design, Level of Evidence   
Sample/Intervention/Findings Strengths and Weaknesses  
Clarkesmith, Pattison, Lip, 





TREAT trial showing the intervention group of 46 
patients had significantly more time in the therapeutic 
range than the usual care group at 6 months (76.2% 
vs. 71.3%; p = 0.035), but not at 12 months (76.0% vs 
70.0%; p = 0.44). 
  
The study was done with 97 adult patients in 2 
locations as a RCT. The intervention was a DVD 
program, handout, diary and worksheet. The usual 
care group of 51 patients received only a handout. 
Patients were followed at 1,2,6, and 12 months 
 
Strengths: TREAT intervention gives patients a 
framework to make behavior changes and 
strategies to maintain a therapeutic INR over 
time. 
 
The teaching intervention is listed that needs to 
be done every 6 months to maintain levels of 
adherence to warfarin therapy. 
 
Weaknesses: Atrial fibrillation often seen 
predominantly in white populations; 234 eligible 
patients declined to participate due to 


















Levels of Evidence from the Appraisal of Literature 
 
Author, Year, Study 
Design, Level of Evidence   
Sample/Intervention/Findings Strengths and Weaknesses  




Level II  
Patients on OAT may benefit from periodic (every 6 
months) educational efforts reinforcing key medication 
safety information, even after initial education and 
ongoing monitoring.  
 
600 patients randomly assigned to one of three 
groups who received warfarin education including 
videos and handouts, or usual care. 
 
317 patients completed both baseline and post-test 
questionnaires. 
 
Patients who had education showed greater gains on 
the questionnaire than those in control group (p < 
.001); they also showed greater positive results in 
their beliefs in the importance of INR (p = .010), and 
believed that taking warfarin was beneficial (p = .012). 
Strengths: The questionnaire demonstrated 
many patients to have dangerous beliefs and 
gaps in their warfarin knowledge 
 
Study found non-adherence a great concern, 
leading to risky behaviors and life-threatening 
adverse events  
 
Weaknesses: patients responding to the 
questionnaire were not supervised and 
minorities were not represented.  
 
The educational strategies had no longer term 















Levels of Evidence from the Appraisal of Literature 
 
Author, Year, Study 
Design, Level of Evidence   
Sample/Intervention/Findings Strengths and Weaknesses  








Study showed insufficient patient education is 
associated with adverse thromboembolic event rates 
in adult patients. 
 
Cumulative risk reduction in experimental group 
versus control group was statistically significant (OR 
0.25, 95%; CI 0.1, <0.01) in multivariate analysis. 
 
Patient knowledge was assessed with an 18-item 
questionnaire, patients received picture booklets.                
 
Strengths: Experimental group had 3 times 
decreased adverse events than control group, 
regardless of patient’s age or economic level. 
 
Weaknesses: The researchers did not control 
the efficacy of the educational program based 
on frequent INR testing; researchers thought 
physicians biased toward experimental group.  
Cook-Campbell and 
Sefton, (2010).  
 
Descriptive Study  
 
Level IV  
36 home care patients (mean age was 79 years) were 
given a survey of 14 questions related to OAT  
 
Basic knowledge of food and medication interventions 
can make a significant impact on reduction of adverse 
effects of bleeding or clot formation. 
 
Older adults may have different needs which may 
hinder their OAT education. 
 
 
6 out of 14 questions were found statistically 
significant for knowledge gained after the educational 
intervention.  
Strengths: Study showed knowledge deficit 
among patients >65 years now home after 
hospitalization, citing mental capacity of elderly 
may be a factor and older adults may have 
different needs that hinder warfarin education. 
 
Home care developed educational program 
based on survey results of OAT.  
 
Weaknesses: small sample size; there was no 
established reliability or validity to 
questionnaire used in the survey. The teaching 
was done by either nurses or physicians, or 
literature was provided, there were no teaching 
guidelines.   





Levels of Evidence from the Appraisal of Literature 
 
Author, Year, Study 
Design, Level of Evidence 
Sample/Intervention/Findings  Strengths and Weaknesses 



















Level IV  
 
100 patients with mechanical heart valves using OAT 
were tested with the 20-item questionnaire, the 
Knowledge Information Profile (KIP).  
 
61% of patients had scores showing insufficient 
knowledge of warfarin, multivariate regression 
analysis showed understanding INR, knowing the 
acronym, age, were the strongest predictors of 
knowledge of OAT.   
 
Patients who received community counseling did have 
significantly higher knowledge of OAT compared to 
those who did not receive any knowledge (p = .001). 
 
 
2 hospital clinics in the UK had 93 patients with atrial 
fibrillation complete a baseline questionnaire followed 
by an educational intervention on OAT.  
 
33 of the 93 clinic patients completed a follow-up 
questionnaire. 
 
The educational intervention significantly improved the 
patient’s knowledge of the therapeutic INR range and 
conditions that may affect INR levels (p = 0.001 and p 
= 0.014) for patients who finished both assessments.  
Strengths: The study used the Knowledge 
Information Profile, a previously validated 
questionnaire.  
 
KIP was translated into different languages and 
accommodated socioeconomic status. 
 
Weaknesses: Patients who received more than 
1 teaching tool may be a confounding factor. 
 
Study was unable to tract INR values for 




Strengths: Patients improved their knowledge 
of atrial fibrillation and its treatment. 
 
Weaknesses: The patient education handout 
was not measured with regard to literacy level; 
the study did not assess the usefulness of the 
handout.  




Levels of Evidence from the Appraisal of Literature 
 
Author, Year, Study 
Design, Level of Evidence 
Sample/Intervention/Findings  Strengths and Weaknesses 




Level IV  
 
100 patients were given a 52-item questionnaire of 
Coumadin knowledge, compliance, drug interactions, 
herbal or vitamin interactions and diet. 
 
Patients were stratified according to their educational 
level. 
 
No knowledge difference related to diet (p = 0.686) or 
drug-drug (p = 0.869) or drug-supplement interaction 
(p = .148).  
 
Data was attributed to high variability in effectiveness 
of OAT and highlight the need for innovative 
educational approaches.  
Strengths: The study had patients reading a 
food label on the questionnaire and found the 
ineffectiveness of the education to be at too 
high a literacy level. 
 
The questionnaire revealed the patient’s lack of 
knowledge regarding vitamins and minerals 
with OAT.  
 
Weaknesses: The questionnaire was not 
validated, the questionnaire was based on 
current practices in education of OAT, and 
patient responses were self-reported.  
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Construct EBP 
Literature Synthesis to Support EBP Recommendations  
 Level I evidence summary and synthesis. Level I evidence from three 
systematic reviews and the one clinical practice guideline showed the evidence to be 
strong for patient educational interventions of OAT. As Nasser et al. (2011) indicated, 
there are multiple challenges of older patients’ knowledge of OAT.  These multiple 
challenges help direct how to assess the patient’s current knowledge. The 
recommendations from these researchers included utilizing a validated questionnaire to 
measure patient knowledge. Providing various patient accesses to education of OAT in 
different practice settings was another recommendation.  
 The clinical practice guidelines from Holbrook et al. (2012) agreed with Nasser et 
al. (2011) that patient education for OAT should be done in a systematic and 
coordinated manner with INR testing and tracking. Wofford et al. (2008) agreed with 
patient education assessment by questionnaire as a systematic and coordinated manner 
to determine education required for OAT, as well as measuring what the patient learned.  
 Nasser et al. (2011) addressed the barrier of older patient’s cognitive functional 
decline as an additional challenge for OAT. Particularly, the assessment review by 
Wofford et al. (2008) discussed the provider’s need to recognize the patient’s reading 
and literacy level related to cognitive function. However, Clarkesmith, Pattison, and Lane 
(2013) examined patient uncertainty about making decisions as a knowledge deficit 
rather than cognitive decline for the older patient. These researchers also discussed 
emotional barriers of OAT, utilized educational booklets at the patient’s reading level, 
and implemented INR testing interventions to facilitate working through these barriers.  
 Clarkesmith, Pattison, and Lane (2013) and Nasser et al. (2011) recommended 
one-on-one or face- to-face patient interactions regarding the questionnaire and patient 
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education on OAT. The information can then be customized for patient need without 
patient embarrassment if lack of knowledge is determined.   
 Wofford et al. (2008) acknowledged the provider to be experienced in OAT and 
names physician extenders who are knowledgeable in OAT to do the patient education. 
The researcher’s endpoints revealed the educational content of education of OAT should 
be that of safety by topic and not include extraneous points of anticoagulation. Wofford 
et al. (2008) also recommended office efficiency to be maximized with the utilization of 
physician extenders, who are knowledgeable using validated instruments with patient 
visits.   
 Clarksmith, Pattison, and Lane (2013), Nasser et al. (2011), and Wofford et al. 
(2008) all acknowledged videos on OAT to augment the educational intervention. In 
addition to the pictorial handout, the video was a take-home reminder of the importance 
of OAT. The video provided reinforcement, convenience, and flexibility for the patient.         
 Level II evidence summary and synthesis. The two RCT’s recommended 
clinicians utilize patient narratives with examples of information on OAT during patient 
interviews. Specifically, education of OAT using educational booklets and measuring 
what patients learned with questionnaires was endorsed to measure effective patient 
education of OAT. Both RCT’s found gaps in the patient’s knowledge regarding OAT 
before patient education began. The two RCT’s showed the importance of monitoring as 
a learning tool for OAT, and looked at monitoring as well as time in therapeutic range as 
teaching tools. Clarkesmith, Pattison, Lip, and Lane (2013) as well as Mazor et al. 
(2008) encouraged patient updates of OAT done by face-to-face educational 
interventions or videos. Specifically, Clarkesmith, Pattison, Lip, and Lane et al. (2013) 
found no difference between the interventional group and the control group with 
knowledge of OAT after six months.   
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 Level IV evidence summary and synthesis.  Pernod et al. (2008) 
recommended an educational intervention for patients on OAT to decrease 
complications of hemorrhage or thromboembolic events. The researchers found the 
impact of an educational program utilizing an 18-item questionnaire and a picture book 
on OAT on clinical adverse event rates were clinically significant no matter the age or 
sociocultural level of the patient. Their best practice recommendations focused on 
greater awareness of the need for education as well as regular INR values monitored 
every one, two, three, or four weeks to lower adverse rates of thrombotic or hemorrhagic 
complications of OAT.   
 Level VI evidence summary and synthesis.  Consistencies within all four 
descriptive studies for the project on OAT included that education to accommodate the 
patient’s literacy level on OAT was needed prior to therapy. Another consistency was 
utilizing a validated tool such as a questionnaire or pretest/posttest to evaluate patient 
knowledge of OAT.  Hu et al. (2006) used the same assessment questionnaire as the 
project on OAT will be using. However, the Knowledge Information Profile was 20 
questions in 2006. It has been decreased to 14 questions by its authors and its literacy 
level measured to that of a sixth grade reading level (Nordstrom et al., 2009).   
 Further consistencies within all four descriptive studies concerned the patient’s 
knowledge deficit and why the patient had the knowledge deficit. Hu et al. (2006) noted 
patients who had incomes less than $25,000 and less than an eighth grade education 
had literacy barriers to knowledge of OAT.  Smith et al. (2010) found the patients at 
highest risk with multiple comorbidities had the lowest knowledge scores. Cook-
Campbell and Sefton (2010) and Lane et al. (2006) discovered patient knowledge 
deficits of over-the-counter medications which were not included in the patient’s 
medication list that affected OAT. The patient did not know the over-the-counter 
medications were important and could make a difference in the INR. Cook-Campbell and 
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Sefton (2010) and Hu et al. (2006) found the patients had knowledge deficits of food 
items containing Vitamin K that affect the INR and the need to reinforce the information 
through written patient education. The researchers listed reasons why the patient may 
have forgotten the information or it was originally poorly understood.  
 Hu et al. (2006) and Lane et al. (2006) agreed that understanding the concept of 
INR and ongoing monitoring of the INR to be strong predictors of improved knowledge 
as well as longer time in therapeutic range.  
 Finally, all four descriptive studies were consistent with recommendations of on-
going community counseling with educational handouts written at a lower literacy level to 
improve patient knowledge about taking OAT.  None of these four descriptive studies 
found an increased knowledge of OAT with duration of therapy.     
Best Practice Model Recommendation   
 Based on the most current and relevant evidence from the literature, the project 
manager identified similarities within the evidence. These similarities indicate that the 
best practice model recommendation for the project included the following:  
1. An experienced APN in the management of OAT for patient assessment, 
education implementation and dosing of OAT (Wofford et al., 2008).  
2. A questionnaire or validated tool in the form of a pretest/posttest which 
determined patient baseline knowledge of OAT (Clarkesmith, Pattison, & 
Lane, 2013; Cook-Campbell & Sefton, 2010; Hu et al., 2006; Lane et al., 
2005; Smith et al., 2010; and Wofford et al., 2008). 
3. The questionnaire was written on a sixth grade reading level (Hu et al., 2006). 
4. A large-print written booklet with pictures was used for the educational 
intervention (Clarkesmith, Pattison, & Lane, 2013; Cook-Campbell & Sefton, 
2010; Holbrook et al., 2012; Hu et al., 2006; Lane et al., 2005; Mazor et al., 
2007; Nasser et al., 2011; Smith et al., 2010; and Wofford et al., 2008). 
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5. The large-print written booklet with pictures on a sixth grade reading level 
was used for the teaching intervention (Hu, et al., 2006; Mazor et al., 2007). 
6. One-on-one educational interventions were provided to the patients 
(Clarksmith, Pattison, & Lane 2013; Cook-Campbell & Sefton, 2010; Holbrook 
et al., 2012; Hu et al., 2006; Lane et al., 2005; Nasser et al., 2011; and Smith 
et al., 2010). 
7. A 12-minute video on OAT was used to augment the educational intervention 
and provided a reinforcement for home use (Clarkesmith et al., 2013; Lane et 
al., 2006; Nasser et al., 2011; Wofford et al., 2008) 
8. Continued INR monitoring in accordance with American College of Chest 
Physicians (ACCP) EBP clinical guidelines was implemented to answer the 
clinical question (Holbrook et al., 2012; Mazor et al., 2007; Pernod et al., 
2008; Wofford et al., 2008)   
 The 2012 ACCP EBP clinical guidelines for OAT used in this project do not 
specify that a questionnaire or pretest/posttest be utilized to measure learning.  
However, the 2012 ACCP EBP clinical guidelines do indicate that patient education be 
conducted in a systematic and coordinated manner. The ACCP recommendations 
included INR testing, tracking, follow-up, and good patient communication of results and 
dosing decisions in patient education. 
Best Practice Recommendation 
 The project manager utilized the eight best practice recommendations found in 
the best evidence regarding the effect of an educational intervention on OAT in a 
primary care setting. Roy’s (2001) Adaptation model for patients and nursing’s role in 
redirecting stimuli facilitated the patient’s adaptation behaviors. The Stetler model (2001) 
identified five phases of project development that promoted critical thinking and guided 
the project.      
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 Permission was obtained to utilize the KIP-C by one of its authors, Feletta L. 
Wilson, PhD. RN, see Appendix A. Patients on OAT were asked to take part in a 14-
question true/false pretest, the KIP-C (Nordstrom et al., 2009), see Appendix B.  These 
patients then had a 25-minute educational intervention using a professionally written and 
illustrated handout constructed on the sixth grade reading level. The illustrated handout 
is located in Appendix C.   
 Key elements of the handout included basics of anticoagulation, risk-benefit of 
OAT and adherence. Patients had their questions addressed on accessing healthcare 
professionals, diet and lab monitoring. Medication interactions and self-care issues had 
precedence. The narrative to the educational handout is located in Chapter 3.  
 The patient viewed a 12-minute video to reinforce OAT and took home both the 
handout and the video. Questions the patient had were answered during the patient’s 
educational intervention. The patient returned to the primary care office in two weeks for 
their follow up appointment and completed the posttest.  
Answering the Clinical Question with the Best Practice Recommendation 
 Effective patient education interventions were utilized in this project. The PICOT 
question was: “Is an oral anticoagulation therapy educational intervention given to adult 
outpatients in primary care effective in increasing the patient’s knowledge two weeks 
after the intervention?” The project leader administered the pretest prior to the 
intervention, provided the educational intervention, and administered the posttest two 
weeks later. The effectiveness of the intervention was graded by the testing scores. 
 
 
.   
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CHAPTER 3 
IMPLEMENTATION OF PRACTICE CHANGE  
Setting and Participants 
 The setting for this EBP project was an adult and geriatric outpatient clinic office 
of three providers with approximately 3500 patients. The nurse practitioner who works 
full time was the project manager for this EBP project .Originally a one physician-owned 
practice since 2005, the full-time nurse practitioner joined the practice October 1, 2007, 
and the part-time nurse practitioner joined the practice in 2013. The practice was sold to 
a local community medical center in a Midwestern city on April 1, 2013. Located seven 
miles from the hospital on its own campus, the practice was renamed as part of a 
medical group. The medical center is an affiliate of a larger health system in Chicago 
and has received Magnet status.  
 The participants for the EBP project were adult and geriatric outpatients who 
were prescribed Coumadin® or warfarin, named in this project as OAT. The participants 
had English as their written and spoken language. They did not reside in long-term care 
and did not have dementia as a diagnosis on their health problem list. The project was 
implemented from September 9, 2014 through January 31, 2015.There were 65 patients 
on OAT in the clinic. There were 38 patients in the project.  
Outcomes 
  The primary outcome was knowledge gained of OAT after an educational 
intervention by the project manager. Permission was obtained by the author (see 
Appendix A) to use a validated 14-item questionnaire, the Knowledge Information 
Profile-Coumadin, (see Appendix B) as the data collection tool to measure intervention 
effectiveness in knowledge gained of OAT. The project manager then used a large-print 
pictorial booklet for the intervention and discussed each topic with the patient. Food 
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models were used during the intervention to create a visual and tactile application of 
foods or beverages which interact with OAT. The patient also viewed a 12-minute video 
on OAT and took both the booklet and the video home for continued reference.  
Intervention 
 The project manager implemented the educational intervention in the clinic. The 
project did not require any financial hardship for the organization or the patient as the 
patient attended the clinic for an appointment, a follow up appointment, or a scheduled 
INR monitoring. The project manager did not receive scholastic reimbursement for the 
project. The project manager spent face-to-face time with the medical center’s IRB 
attorney for the project proposal, consent, authorization form, data collection tool, 
educational tool, and protocol. Nursing Research Council from the medical center 
approved the same forms. Consent was provided by the Valparaiso University’s IRB for 
the project prior to implementation.  
 The project was implemented in the office during routine office visits, a follow up 
visit, a walk-in visit, or a scheduled INR monitoring. These four patient encounters 
showcased the Stetler model (2001). The model identified affirming perceived problems 
with internal evidence. The desired measureable outcomes were attained with the 
educational intervention. Roy’s perception of individual adaptation congruently found the 
patient in a position for learning with the APN who evaluated the patient’s adaptation on 
a continuum.   
 As the evidence illustrated, a questionnaire should be used to measure the 
direction of the education (Clarkesmith et al. 2013; Cook-Campbell & Sefton 2010; Hu et 
al. 2006; Lane et al. 2006; Mazor et al. 2007; Smith et al. 2010; Wofford et al. 2008).  
The KIP-C true/false questionnaire was given to the patient at this time and 
alphabetically coded for protection of human subjects and HIPPA privacy. The 
questionnaire was stored in a locked drawer of a locked office until data retrieval. The 
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KIP-C was written on a sixth grade reading level. Current evidence supported 
recognizing literacy issues of the adult patient (Hu et al., 2006; Mazor et al., 2007).  
 Face-to-face or individual patient interaction was addressed in the evidence as 
best practice (Clarkesmith et al., 2013; Nasser et al., 2011; Smith et al, 2010). The 
project manager used a 25-minute face-to-face anticoagulation therapy educational 
intervention utilized the booklet, Blood Thinner Pills: Your Guide to Using Them Safely 
(Huber, 2005) (see Appendix C). The 12-page, large-print pictorial booklet covered the 
following topics:  
 1.  The name of my blood thinner 
 2.  About your blood thinner 
 3.  How to take your blood thinner 
 4.  Check your medicine 
 5.  Using other medicines 
 6.  Possible side effects 
 7. Stay safe while taking your blood thinner 
 8. Food and your blood thinner 
 9. Talk to your other doctors  
 10. Blood tests 
 11. Common medical conditions  
The educational intervention was clarified in each page of the handout and allowed the 
patient to write a note or mark important points to remember. The evidence supported 
written materials for patient use (Clarkesmith et al., 2013; Cook-Campbell and Sefton, 
2010; Holbrook et al., 2012; Hu et al.,2006; Lane et al., 2006; Mazor et al., 2007; Nasser 
et al., 2011; Smith et al., 2010; and Wofford et al., 2008). Within the intervention, the 
project manager followed a regular pattern of questions and answers pertaining to each 
of the subjects listed above and located in the handout. Clinical guidelines (Holbrook et 
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al., 2012) addressed a systematic and coordinated approach, good patient 
communication of results and dosing decisions in patient education. The project 
manager noted the patient’s response to each topic based on his or her current 
knowledge of OAT. Evidence of provider knowledge was included in best practice 
(Wofford et al., 2008).  
 The patient returned to clinic two weeks later to take the questionnaire as the 
posttest, which was also the KIP-C. It was coded and stored in the same manner as the 
pretest.  
Planning 
 Planning well in advance of implementation was required before the project was 
developed. The project manager met with the physician and other nurse practitioner for 
guidance and suggestions for implementation. The methods of implementation were 
adjusted for the older adult, such as a slower-paced, large-print booklet on a lower-
literacy level, the use of food models and reinforcement of the information with a video.  
Permission had been granted to use the KIP-C tool from the author (see Appendix A). 
The patient booklet was cited in the references of this project (see Appendix C) and is in 
public domain; it may be used and reprinted without permission.  
Recruiting Participants  
 Patients were identified using the clinic’s EMR. A listing of patients was also 
available. The listing was only known to the project manager as patients are tracked for 
timeliness of INR monitoring. As patients who reside in long-term care and with 
dementia were omitted, the remaining patients were offered the OAT educational 
intervention. Patients came to the office for a routine office visit, a follow-up visit, walk-in 
visit, or for monitoring their INR, so there was not a hardship coming to the clinic for 
either the questionnaire or the intervention. Patients who agreed to take part in the 
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intervention signed a consent form (see Appendix D) and an authorization form (see 
Appendix E).   
Data 
Reliability and validity  
 Two-thirds of the patients eligible for this study were over 70 years old. Literature 
indicated (Hu et al., 2006; and Nasser et al., 2011) that older adults may not use 
medication correctly and have poor adherence as a result of lack of understanding. In 
OAT, poor adherence occurs with 10-26% of patients, but is more pronounced in the 
older population (Wilson et al., 2003). The older adult may not be able to process or 
remember the information about OAT due to (a) poor understanding, (b) polypharmacy, 
(c) impaired reasoning from the effects of cardiovascular diseases or medication side 
effects, (d) multiple sensory impairment, e) difficulty with word recognition, and (f) lack of 
concentration (Wilson et al., 2003).  
 One of the authors of the KIP-C, Feleta Wilson, PhD, MPH, BSN, RN, FAAN, is 
an associate professor in the College of Nursing at Wayne State University, Detroit, 
Michigan. Dr. Wilson has championed health literacy and patient education for the past 
20 years. Originally named “KIP”, the Knowledge Information Profile was a 20-item 
true/false questionnaire that was used in 2003 in a study of 60 patients at an oral 
anticoagulation clinic. Content validity of the KIP was confirmed by a group of six 
professionals in anticoagulation therapy and gerontology. In addition, other validity 
characteristics included: 
 1. KIP provided a definite purpose of defining knowledge of medication action,  
  drug interaction and food sources of Vitamin K  
 2. Food, beverage or medication characteristics were common among patients in 
  age groups, English speaking, and African American 
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 3. The subjects were determined to be physically and mentally able to participate 
  in the study   
 4.  The questionnaire measured patient knowledge using true and false   
  answers 
 5.  The questionnaire captured culturally-based scenarios that were realistic to  
  the patient 
 6.  The KIP was compared to the REALM (Rapid Estimate of Adult Literacy in  
  Medicine) evaluation during the study, which is a word recognition test to  
  help assess adult learning capacity (Wilson et al., 2003; Stiggins, 1987) 
 KIP reliability for this study was 0.80. In addition, reliability was demonstrated as 
the pharmacist, APN’s, and physicians were trained in OAT and assessed for 
consistency (Wilson et al., 2003). Rater bias was minimized through training and cultural 
awareness in the anticoagulation clinic (Wilson et al., 2003). This provided a common 
environment for both the patient and professionals (Wilson et al., 2003).  
 Results of the KIP study showed a significant relationship between literacy and 
education (p < 0.01). An inverse relationship was found between age and literacy (p < 
0.01). The study found literacy levels decreased as age increased. In addition, as age 
increased, knowledge about food and medicine decreased (p < 0.01) (Wilson et al., 
2003). 
 In 2009, Dr. Wilson and colleagues modified the assessment tool to the current 
KIP-C, which was shortened from 20 to 14 questions (Nordstrom et al., 2009). Dr. 
Wilson and colleagues studied 192 patients with similar backgrounds and the same 
clinic site as the first study. The researchers tested psychometric properties of test-retest 
score reliability. They also correlated the patient’s length of OAT therapy with knowledge 
scores for construct validity. Dr. Wilson and colleagues hypothesized that more patient 
knowledge would be related with more literacy (Nordstrom, et al., 2009). The REALM 
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and demographic profiles were again used. The posttest was completed two weeks 
later. This period of time was selected because this was sufficient time to detect a 
change in knowledge between pre-/posttests and to measure INR consistency in 
therapeutic range (Nordstrom, et al., 2009).  
 The KIP-C correlated with pre-/posttests (p < .0001) suggesting test-retest 
reliability. The KIP-C pretest correlated with the REALM (p = .005). The posttest follow-
up correlated with the REALM (p < .0001) as well as the patient’s time using Coumadin  
(p = .01) supporting construct validity.  
Data Collection  
 The 14-question KIP-C took the patient less than ten minutes to complete. The 
questions represented Vitamin K foods and knowledge, side effects of OAT and other 
foods, beverages and medications related to OAT. The eight points of demographics for 
each patient included (a) age range, (b) gender, (c) level of education, (d) indications for 
OAT, (e) if the patient ever had previous teaching on OAT, (f) how long ago the teaching 
was, (g) duration of OAT, (h) and was a partner listening to the intervention.    
 After explanations of the consent and authorization forms and signatures of the 
same, the patient took the pretest. Any questions the patient had after the pretest were 
answered. The educational intervention was done after the pretest. Two weeks later, the 
patient returned to clinic for a follow up to their office visit, or for an INR check and 
completed the post-test. The entire project was done by the project manager.   
Management and analysis   
 Pretest and posttest questionnaires were placed in a participant folder.  The 
folder was labeled alphabetically and corresponded to a list of patient names for 
reference. Only the project manager had access to this information. The folder was 
placed in a locked desk drawer which was only accessible to the project manager. The 
desk was inside a locked office.  
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 Descriptive data were calculated. Scores of the pretest/posttest were calculated 
with 78% as the passing grade to show competency and mastery of the topic. An 
analysis was run to see where any teaching topic was missed or the patient failed to 
learn the material. The number of questions correct was expressed in percentages. 
Paired t tests were be used to assess differences in pretest/posttest scores. The scores 
were correlated in all eight demographic points.   
Protection of Human Subjects      
 The project manager received a certificate of completion from the National 
Institutes of Health (NIH) Office of Extramural Research.  This was achieved by 
completing the NIH Web-based training course “Protecting Human Research 
Participants”.  The project manager also completed the Collaborative Institutional 
Training Initiative (CITI) for social and behavioral research, also via a web-based training 
course. The project was approved by expedited review by the Valparaiso IRB, and was 
















The purpose of the OAT project was to answer the PICOT question “Is an oral 
anticoagulation therapy educational intervention given to adult outpatients in primary 
care effective in increasing the patient’s knowledge two weeks after the intervention?” 
Patients who participated in the OAT project completed pretest/posttest questionnaires 
and submitted INR data, or were knowledgeable of their INR data utilized in the project. 
Data were analyzed using the SPSS statistical program. Information identifying patients 
was not included and the program was double password protected. Patient test scores, 
INR data, and demographic variables were entered and a descriptive analysis was 
conducted. The data were analyzed using descriptive statistics in (a) measures of 
central tendency, (b) prediction and association, (c) parametric inferential statistics, and 
(d) nonparametric inferential statistics.  
Sample 
Forty patients began the project and 38 completed the project. The participation 
rate was 95% (N = 38). The intervention was given over a 16-week period from 
September 9, 2015 to January 31, 2015. The two patients (5%) who did not complete 
the project became ill prior to their posttest and did not complete the posttest. Both of 
these patients were male, had atrial fibrillation, were age 79 and 80 respectively.     
For the 38 patients who were in the project, the pretest provided information 
about their knowledge of OAT through 14 true/false questions. Eight demographics were 
assessed, including (a) age, (b) last completed grade in school, (c) gender, (d) if the 
participant had education on OAT in the past, (e) how long ago the patient received 
education on OAT, (f) duration of OAT, (g) indication for OAT, and (h) if a spouse or 
partner had also heard the intervention (see Table 4.1 and Figures 4.1 to 4.5). Ten 
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(26.3%) of the 38 patients denied having any previous education of oral anticoagulation 
therapy. 
An independent t test was calculated comparing the mean score of patients who 
had a spouse or significant other listen to the educational intervention and the mean 
scores of patients who did not have a spouse or significant other listen to the 
intervention. The mean score of the patient who had a spouse or significant other listen 
to the intervention (M = 12.00, SD = 4.24) was not statistically different from the mean 
score of the patients who did not have a spouse or significant other listen to the 
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Table 4.1     
Patient Characteristics  
        n (%)        M (SD) Range/Years 
Age                      38 (100)        74.7 (10.1) 48 
        
Highest Grade Completed in 
School            13.4 ( 2.6)   
         Less than 12th grade         4 (  10)           
         High School     15 (  39)     
         Trade School or College     19 (  50)     
        
Gender       
         Male     18 (47.4)     
         Female     20 (52.6)     
        
Educational History of OAT        
         Yes    28 (73.7)     
         No    10 (26.3)     
        
How Long Ago was the OAT 
Education? (years)          5.13 ( 5.2) 21 
        
Duration of  OAT Therapy (years)          6.50 ( 4.8) 20 
        
Reason for OAT Therapy       
       Atrial Fibrillation    26 (68.4)     
       Valve Replacement      2 (  5.3)     
       Embolus      7 (18.4)     
       Stroke      2 (  5.3)     
       Other      1 (  2.6)     
        
Did Spouse/Partner Hear the 
Teaching Intervention?                   
        Yes    10 (26.3)      
        No    20 (52.6)     
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Figure 4.1  
Age Distribution of OAT Project 
 
Figure 4.1 Age distribution of the population who participated in OAT project. The 
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Figure 4.2  










Figure 4.2 Indications or reasons patients listed as why they were using OAT.  
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Figure 4.3  
Previous Education of OAT 
 
Figure 4.3 Participants were asked how many years ago they had received oral 
anticoagulant therapy teaching. Ten participants listed they had never had oral 
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Figure 4.4  
Duration of Oral Anticoagulation Therapy 
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Figure 4.5  
Spouse/partner Participation during the Intervention  
 
Figure 4.5 The eight patients who responded “not applicable” did not have a 
spouse or partner to hear the intervention. Those who replied “no” did have a 
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Outcomes 
 Statistical testing. SPSS Base 18 statistical program was used to analyze the 
data. Information identifying the subjects in the project was not included and the program 
was double password protected. 
 Significance. Pretest scores on the KIP-C ranged from three correct (21%) to all 
14 (100%) of the questions correct.  A passing score was 78%. A total of 26 (68%) 
patients passed the pretest and 35 (92%) patients passed the posttest. The same two 
patients scored 100% on both the pretest and the posttest. There were two (5%) patients 
who did not pass either the pretest or posttest; one was over age 80. Four (10%) 
patients scored more incorrect answers on the posttest than the pretest. There were 
nine (23%) patients between the ages of 80-89, and one (2.5%) was aged 90. Of the 10 
patients who were over 80, six (15%) of them scored more correct answers on the 
posttest than the pretest.  
 To answer the PICOT question, a paired samples t test was calculated to 
compare the mean pretest score to the mean posttest score. The mean pretest was 
11.16 (SD= 2.24), and the mean posttest score was 12.58 (SD= 1.44). A statistically 
significant increase from pretest mean score to posttest mean score was found (t (37) = -
4.651, p < .001). 
 Overall benefits of the educational program included patients’ renewed interest in 
foods, beverages, and medications, both prescription and over-the-counter, which would 
interfere with OAT. Patients mentioned their booklet or video as reference in subsequent 
office visits when asked about any bleeding from OAT. Another reported benefit included 
several patients who verbalized an exact dose of OAT made their INR more stable from 
week to week.  
 Secondary outcomes were also analyzed. A paired samples t test was calculated 
to compare the mean pretest INR to the mean posttest INR, which was done two weeks 
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after the pretest. Not all of the 38 patients had their INR value drawn at the time of 
posttest. Eleven participants were scheduled to recheck INR values at three or four 
weeks. At two weeks, 27 of the 38 patients had a mean pretest INR of 2.07 (SD = .66) 
and the mean posttest was 2.83 (SD = 1.88). No significant difference from pretest INR 
to posttest INR was found (t (26) = -2.002, p > .056). However, these INR differences did 
show clinical changes approaching a significant change.  
 Pearson Correlation coefficients were calculated for the relationships among the 
patient’s age, highest grade achieved in school, how long ago their education was on 
OAT, and duration of warfarin therapy (see Table 4.2). A strong positive correlation was 
found (r (36) = .889, p < .001), indicating a significant linear relationship between the two 
variables of how long ago the participant had education on OAT with their duration of 
warfarin therapy.  
 A Cochran’s Q test was conducted to assess for differences in the patient’s INR 
results at four, six, eight, ten, and twelve weeks. No significant differences were found 
(X²(4) = 4, p > .406). On the average, there were changes to patients’ INR’s, which 
included INR values above, within, and below therapeutic range (see Table 4.3). Follow-
up INR values ranged from 1.1 to 5.7 (M = 2.50, SD = 1.02). By week 4, the majority of 
patients were within the therapeutic range; however, the number within therapeutic 
range continued to decline following week 4. For week 10, the fewest number of patients 
returned for an INR and these patients had the fewest members within therapeutic 
range.   
Cronbach’s Alpha is a measure of internal consistency and tests for reliability of 
test construction (Cronk, 2012). For the project on OAT, Cronbach’s Alpha was used to 
determine the degree to which all the items in the pretest and posttest measured the 
patient’s knowledge of OAT. The reliability coefficient was 0.720, for each testing period 
which represented good internal consistency.  
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 Test-retest reliability (Cronk, 2012) is a measurement of temporal stability that 
tells whether or not the instrument is consistent over time or over multiple 
administrations. Pearson Correlation coefficients were completed on pretest/posttest 
total scores. The test-retest reliability of the KIP-C was .56, showing moderate test-retest 
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Table 4.2  












Age Pearson Correlation  -.066 .047 .034 
Sig. (2-tailed)  .695 .778 .842 
N  38 38 38 
Highest grade 
completed in school 
Pearson Correlation   .166 .131 
Sig. (2-tailed)   .319 .433 
N   38 38 
How long ago was OAT 
teaching?  
Pearson Correlation    .889** 
Sig. (2-tailed)    .000 
N    38 
Duration of OAT  Pearson Correlation     
Sig. (2-tailed)     
N     
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Table 4.3    
 






n = 38 
2 weeks 
n = 27 
4 weeks 
n = 21 
6 weeks 
n = 16 
8 weeks 
n = 21 
10 weeks 
n = 12 
12 weeks 
n = 19 
A-1 1.0 2.5      
B-2 3.0 1.9      
C-3 2.8 2.9 3.0. 2.7    
D-4 1.3 7.2 3.2     
E-5 2.2 2.4 2.9 2.4 2.9   
F-6 2.2 1.9 1.8 2.4 2.0   
G-7 2.7 3.4 3.5 2.5 2.3 2.7  
H-8 3.5    2.1   
I-9 2.0 2.0      
J-10 2.2 1.9  2.3    
K-11 3.1 2.6  2.7    
L-12 1.6 1.7 1.7 1.5 1.5 1.3  
M-13 2.2 2.3  2.3  2.7 1.7 
N-14 2.1 2.2  3.0 2.4 3.5  
O-15 1.7 2.9  1.5 2.5   
P-16 1.2 1.9  1.6 2.1 1.7  
Q-17 1.2 2.4 3.4  1.3 1.1 1.5 
R-18 1.5 2.6 2.7  1.8  2.3 
S-19 2.7 4.1 2.3  2.1  4.3 
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Table 4.3    





n = 38 
2 weeks 
n = 27 
4 weeks 
n = 21 
6 weeks 
n = 16 
8 weeks 
n = 21 
10 weeks 
n = 12 
12 weeks 
n = 19 
-21 2.2  2.3  1.6  5.7 
V-22 1.9  2.0  2.0  2.1 
W-23 1.4 2.0  1.8 2.3 1.3 2.2 
X-24 3.1      2.8 
Y-25 2.7  2.7  3.6 2.6 3.0 
Z-26 1.8 2.8    1.6 1.8 
AA-27 1.1 3.0 2.0 2.1 1.9 2.0 1.8 
BB-28 1.7 1.9 2.6    2.4 
CC-29 2.5  2.3  2.9  2.4 
DD-30 3.2 1.6      
EE-31 2.0  2.0  1.8  1.8 
FF-32 2.3  2.8    2.3 
GG-33 2.7 10.5 1.3  1.8  1.2 
HH-34 2.0 1.9  2.2  2.8  
II-35 2.7  1.4 3.5  3.0 2.4 
JJ-36 3.1  2.3  2.0  2.5 
KK-37 2.6 1.7  3.3    





50% 52% 67% 60% 62% 29% 58% 


















Note: Red values = Indicate INR within therapeutic range 




 This EBP project was implemented to determine if an educational intervention 
given to outpatients in a clinic setting who used OAT resulted in knowledge gained two 
weeks after the intervention. Analyses were conducted for the 38 patients who 
participated in the project. Results of the patients’ educational intervention scores, the 
patients’ demographic data, and their INR data over 12 weeks of the project were 
analyzed and tabulated. The outcomes of this project demonstrated that implementation 
of an educational intervention can improve knowledge of OAT. However, the effect of 
education on patients’ INR values demonstrated inconsistent changes over time.   
Explanation of Findings 
 Patients mean scores demonstrated a statistically significant difference (-4.651; p 
< .001) from the pretest to the posttest. In comparing this project with the levels of 
evidence cited, the systematic review by Clarkesmith et al. (2013) noted two trials of 
patients who had inadequate knowledge of control of OAT improved their knowledge 
with a questionnaire and an educational intervention. Nasser et al. (2011) noted that 50 -
80% of older patients using OAT who completed a questionnaire had inadequate 
knowledge of anticoagulation control. Nasser et al. (2011) also found significantly higher 
questionnaire scores in patients who were taught face-to-face (13.9 out of 20 compared 
to 12.4; p = 0.08). All the patients in this project were taught face- to-face, and 92% 
passed the posttest. The RCT by Mazor et al. (2007) found that patients who had 
teaching showed a statistically significant (56 pretest/70 posttest; p < .001) knowledge 
improvement with pretest and posttest questionnaire. The descriptive study by Hu et al. 
(2006) also showed 61% of the patients had insufficient knowledge of OAT, and added 
that patients who had counseling showed a statistically significant higher knowledge 
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scores (-2.65 (-3.8 to -1.5; p = .001) than patients who did not receive any counseling. 
Another descriptive study by Lane et al. (2005) showed questionnaire scores to be 
statistically significant in improved patient knowledge (22 out of 33; p = 0.001).  
 Patients in the study by Lane et al. (2005) were also knowledgeable about 
conditions affecting their INR level (19 out of 33; p = 0.014) One descriptive study by 
Smith et al. (2010) cited patients who were not found to have any knowledge difference 
related to diet or medications with a questionnaire were given educational materials at 
too high a literacy level. The literacy level of the questionnaire as well as the large print 
educational booklet used in the EBP project was on the 6th grade level, the mean 
educational level of patients in the EBP project was 13 years. The lower educational 
level of the questionnaire likely enabled more patients in the project on OAT to pass the 
pretest/posttest.   
 The EBP project was also done to see if the teaching intervention also improved 
patient INR stability. There were no statistically significant results obtained in either the 
pretest to posttest INR values (t (26) = -.2.002, p > .056) or the INR values achieved in 
weeks 4 through 12 (x²(4) = 4, p > .406). However, the INR values from pretest to 
posttest were approaching statistical significance and did reach clinical significance. In 
addition, there were trends in the INR values over the 12 weeks. In this project, the 
patients’ INR results were in therapeutic range approximately 29% to 62% of the time 
over three months. Initially, the percent of patients with INR values in the therapeutic 
range increased, but then the percent decreased over time.  
 The findings from this EBP project may be due to the irregular method of INR 
checking done the patients in this project. Many patients are directed to recheck their 
INR but do not do so when asked and get their INR checked when they remember or 
when their scheduled allows. The INR instability results also may be attributed to the 
variability of the OAT itself. For example, the populations studied by Pernod et al. (2008) 
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were found in range approximately 64% of the time. The INR instability also may be 
related to patients not taking OAT as prescribed or utilizing medications, foods, or 
beverages that interfere with synthesis of OAT. One SR by Clarkesmith, Pattison, and 
Lane (2013) found two trials that reported improved patient INR control over three 
months with patients who had an educational intervention and improved the percentage 
of time spent in therapeutic range. The same SR by Clarkesmith, Pattison, and Lane 
(2013) noted INR value improvement over three months with patient education and the 
percentage of time spent in therapeutic range improved. The RCT by Clarkesmith, 
Pattison, Lip, and Lane (2013) found the group who had the educational intervention 
spent statistically significant more time in the INR therapeutic range than the usual care 
group (76.2% vs. 71.3%; p = 0.035), but this only occurred for a six month period of time.  
Due to this statistic, the researchers recommended the educational intervention to be 
done every three to six months to maintain patient levels of adherence (Clarkesmith, 
Pattison, Lip, and Lane, 2013). Mazor et al. (2007) also noted that patients on OAT may 
benefit from educational efforts every 6 months even after initial education and ongoing 
monitoring related to non-adherence.     
 Atrial fibrillation was listed as the major reason for OAT use (68%) among the 
patients in this EBP project. Atrial fibrillation is seen predominantly in white populations 
as noted in the RCT by Clarkesmith, Pattison, Lip, and Lane (2013). The entire 
population of this EBP project was white. The SR by Clarkesmith, Pattison, and Lane 
(2013) and the descriptive studies by Lane et al. (2005) and Smith et al. (2010) 
discussed populations with atrial fibrillation but did not specify the white population with a 
higher percentage of atrial fibrillation.     
 The descriptive study by Cook-Campbell and Sefton (2010) noted the mean age 
of the population surveyed was 79 years. The mean age of the EBP project patients was 
74 years. Cook-Campbell and Sefton (201) noted patients who were older than 65 had 
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knowledge deficits about warfarin and cited the mental capacity of the older adult may 
be a factor. The findings from this EBP project did not show mental capacity to be a 
factor as 68% passed the pretest and 92% passed the posttest. The pretest and posttest 
were written on a 6th grade level which may have contributed to a higher percentage of 
patients who passed both the pre- and posttest. The project population showed a higher 
literacy level as their average last completed grade in school was 13.  
 In reference to the pretest/posttest, Cronbach’s Alpha (Cronk, 2012) was used as 
a measure of internal test consistency and reliability. The reliability coefficient was 0.720 
for both the pretest and the posttest. This represented good internal consistency.  
Pearson correlation coefficients were completed on pretest/posttest total scores. The 
test-retest reliability of the KIP-C was .56, showing moderate test-retest reliability. Using 
a tool that showed reliability supports the findings in this EBP project, and the reliability 
results in this project mirrored findings in the literature (Hu et al., 2006).     
 Although the EBP project did not find the low percentage of therapeutic range to 
be attributable to the effects of aging and comorbidities, the low percentage of patients 
within therapeutic range could be related to adherence as well as monitoring 
infrequency. Patients who knew they have used Vitamin K antagonist foods, beverages, 
and medications which interfere with therapeutic INR values may have not done their 
INR value when requested and therefore contributed to monitoring infrequency. 
Evaluation of the Theoretical Framework 
  Roy’s Adaptation model. Sister Callista Roy developed the theoretical 
framework used to guide the EBP project which described adaptation in life’s responses 
and illustrated the effects of focal stimuli, contextual stimuli, and residual stimuli upon 
adaptation (Phillips, 2010). Focal stimuli were the immediate responses facing the 
individual. In this project, it was the patients’ need to understand their cardiovascular 
processes and realize the need for OAT. Contextual stimuli added many factors which 
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increased the impact of the focal stimuli, that being the cardiovascular processes which 
require OAT and learning how the medication works as well as its side effects. Residual 
stimuli are numerous environmental factors such as the interaction of lifestyle, foods, 
medications, or beverages that patients on OAT may choose to use in moderation or 
omit from their intake. Although residual stimuli may be unclear to the patient, the patient 
constantly is in a pattern of coping and adapting to a changing environment with 
responses that promote integrity as well as responses that are ineffective (Phillips, 
2010). The educational intervention of this project on OAT was integrated into the 
patients’ coping and adapting to their changing environment, thus promoting more 
responses which facilitate medication therapy using OAT.   
 Roy (2011) further explains adaptation modes of physiological, self-concept, role 
function, and interdependence that was apparent in this EBP project. Patients often 
questioned their body’s physiological response in cardiovascular or hematological 
wellbeing. Patients were challenged with self-concept when they agreed to take both the 
pretest and posttest questionnaire to determine what they understood about OAT. Role 
function was realistic and pragmatic as the patients admitted their understanding of day-
to-day life utilizing OAT.  
 Role function in adaptation was revealed for 10 patients who had a spouse or 
significant other listen to the educational intervention. These 10 patients expressed not 
only their knowledge of OAT but also their interdependent relationships with their spouse 
or significant other. They uncovered their compliance or lack of compliance of OAT to 
their spouse or significant other during the educational intervention. Patients also 
verbalized their appreciation when taking part in the EBP project as well as their 
gratitude for the education they had received. This was particularly expressed by 
another 10 patients who listed they had never had education on OAT.  
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 Roy’s Adaptation model was a good fit for this EBP project as it allowed the 
project manager to continuously observe the patients’ self-concepts in their role while 
using OAT. The Roy Adaptation model also allowed the project manager to address 
individual patient variables related to the patient’s OAT dosing, day-to-day use, and any 
side effects, thus facilitating patient adaptation. Non-effective patient adaptation was 
identified by the Roy Adaptation model so that the project manager could bring to the 
patient’s attention his/her needs. The Roy Adaptation model allowed the project 
manager to redirect the patient to pragmatic knowledge development with OAT.  
 Strengths of the Roy Adaptation model included ease of assessment in 
appropriate and necessary nursing interventions which helped the patient flow through 
the focal, contextual, and residual stimuli. In applying this concept, the patients quickly 
understood that OAT may be easier to control, they could succeed in this project with 
questionnaire participation, and that the project was being done for their benefit so they 
could learn about OAT. The project also disclosed that 10 patients (27%) of the patients 
who participated never had previous teaching of OAT.  
 Patient adaptation was also evident through the teaching intervention with the 
booklet as well as the video, some patients liked the booklet better and others preferred 
the video format. Patients’ coping skills were examined through their preferred method of 
learning. Patients took home both the booklet as well as the video to promote further 
adaptive responses and increase awareness of their ineffective coping responses while 
utilizing OAT.  
 Weaknesses of the Roy Adaptation model included the four modes of adaptation; 
all the modes were considered a process and may be considered weak when a quick 
decision needed to be made. However, quick decisions were made by patients for 
emergent bleeding during this EBP project’s time frame. One patient went to the 
emergency room for sudden bleeding related to a medication interaction. Another 
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weakness of the Roy Adaptation model implied that the patient would learn to problem 
solve as the patient learned what was taught. Four (10%) patients scored more 
questions incorrect on the posttest than the pretest, which inferred they did not learn. 
The four patients who scored more incorrect responses on the posttest than the pretest 
could suggest poor problem solving, guessing the answers, or maladaptive learning 
behaviors. A third weakness was implied nursing assessment or intervention. Although 
cited as a weakness, this was considered a strong point of the Roy Adaptation model 
(Phillips, 2010) as nursing assessment and intervention were actively pursued with each 
patient.   
Evaluation of the EBP Framework 
 The Stetler model for EBP.  The Stetler model (2001) for individual use allowed 
the project manager to engage in critical thinking, actively analyze current practice 
patterns, and provided opportunities to reflect and improve practice. The Stetler model 
(2001) had five phases to facilitate EBP that included (a) preparation, (b), validation, (c) 
comparative evaluation/decision making, (d) translation/application, and (e) evaluation.  
 Naming the problem and the change agent were a part of preparation phase. 
Included in the preparation phase was locating internal evidence within the clinic which 
found patients using OAT not in therapeutic range related to knowledge deficits, 
monitoring infrequency, Vitamin K antagonist use, and adherence. During the 
preparation phase, external evidence was found in the literature related to the clinical 
problem and presented plausible solutions in RU and EBP. Ranking the studies by levels 
of evidence was completed in the validation phase. Locating the barriers to the practice 
change and addressing the barriers were in the comparative evaluation/decision making 
phase. Synthesizing what the studies were conveying and finding common threads 
related to the strength of the evidence was found in the comparative evaluation/decision 
making phase. The translation/application phase included cognitive application of 
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validating current practice and experiencing an increased awareness of what the 
patients did not understand. The cognitive application provided a method to develop the 
multiple-method teaching intervention for the project on OAT. The evaluation phase 
allowed an ongoing formative evaluation which looked at both the patient and provider 
experiences of the educational intervention. Clarifications of the information to depict the 
change in practice and progressing with the change in practice were within in the 
translation/application phase. Proceeding with the change in practice as well as finding 
ways to keep the change in practice current and applicable was in the evaluation phase.  
 The Stetler model was a good fit as it revealed both internal and external 
evidence to be exposed and continuously reassessed. Both types of evidence provided 
convincing reasons to pursue the project. The Stetler model included patient preference 
or wishes which added to internal evidence. The comparative evaluation/decision 
making phase also allowed an individual project manager to look at the project 
feasibility, risk, resources, and readiness. This project examination endorsed a 
pragmatic fit and flowed well in current clinical practice with present and upcoming 
quality measures.  
 Strengths of the Stetler model included more direction for one project manager to 
examine EBP as well as the use of RU. The phases of the Stetler model helped prevent 
the project manager from using research inaccurately (Romp & Kiehl, 2009). Other 
providers who worked with the project manager also developed and verbalized critical 
thinking skills and named this project as a high priority. The practice method provided by 
the Stetler model facilitated the program’s development for OAT. It can also serve as an 
exemplary model for future program and practice development. 
 Weaknesses of the Stetler model included overlapping phases which caused the 
project manager to go back to a previous phase, such as whether to use group or 
individual classes to teach patients regarding OAT. Strength of the evidence did support 
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individual classes, and in this case, overlapping phases was not a hardship. Applying the 
evidence in Phase IV was not as detailed for the project manager as outlined in the 
literature. The lack of detail in Phase IV was another weakness. A final weakness 
included adapting the findings into practice instead of adopting the findings into practice. 
The findings will not be adapted into practice instead of adopted into practice as the 
project manager’s has utilized the questionnaire, booklet, and video for anticoagulation 
teaching as was completed in the project. The questionnaire will be part of the EMR and 
used as a quality indicator in documentation for reimbursement.   
 There were no modifications to the project. If the EBP project was repeated, 
electronic access would be needed for the questionnaire as documentation of a quality 
measure for the patient on OAT. If the large-print educational booklet on OAT was 
needed in Spanish for the educational intervention, a Spanish language version is 
located at the same web site as the English version. Currently the teaching booklet for 
warfarin therapy at the medical center is written at the ninth grade reading level. The 
large-print picture booklet used in this project is written on the 6th grade reading level 
and has received the approval from the director of pharmacy.  Next, the booklet will need 
to be approved by the Pharmacy and Therapeutics Committee for its utilization 
throughout the medical center. Several of the levels of evidence have already been used 
by a committee to form a Coumadin® Clinic for the medical center and community.  
Strengths and Weaknesses of the EBP Project 
 Strengths of the EBP project included the high-quality levels of evidence that 
were located to construct the plan and the educational intervention. Multiple learning 
strategies were found in the evidence, thus facilitating patient learning through 
questionnaires, large-print picture booklets, food models, and audiovisuals. Assessing 
patient demographics was highly emphasized in the evidence to learn about population 
characteristics. Additional strengths included (a) the evidence had statistical significance 
THE EFFECT OF AN EDUCATIONAL INTERVENTION ON OAT                          96 
 
which supported the project’s analysis, (b) the KIP-C questionnaire still showed 
consistency and reliability, (c) the questionnaire promoted patient learning, (d) the 
questionnaire was used as tool to measure patient outcomes, and (e) the educational 
intervention started or revisited patient teaching on OAT.   
  Further strengths included the need to do the project for a population who 
admitted not having education on the medication they were taking or not having any 
refresher information on utilization of OAT for many years. Also, the project was 
conducted in the outpatient arena where the patient could put what was learned into 
practice as well as having the teaching materials available for continued reference. The 
attitudes of the patients who took part in the project were of particular benefit for the 
project manager as well as a major strength. Patients verbalized that they were 
extremely pleased to take part in the project for their own edification. A final strength of 
the project was that there is now an educational intervention in place for patients who 
are new to OAT. Since the completion of the project, the educational intervention has 
already been used six times for new patients starting on OAT; none have been 
hospitalized with side effects.      
 A weakness of the EBP project was the small size of the population who 
participated. A number of patients were found to have dementia or already had dementia 
on their EMR and did not qualify for the project. Another reason for the smaller sample 
size was the number of patients who only saw the physician and not the project manager 
for their office visit. Patients who only saw the physician left the office before the project 
manager could approach them about participation. Another weakness was the entire 
population of the project was Caucasian and 68.4% had atrial fibrillation for a diagnosis 
in this project. Atrial fibrillation does primarily affect the Caucasian population 
(Clarkesmith, Pattison, Lip, & Lane, 2013). A further weakness was the attrition rate; it is 
unknown whether or not questionnaire scores as well as INR values over 12 weeks 
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would have been different than the population in the project; however, the attrition rate 
was only two patients.  
  The time it took to implement the project was a factor; the educational 
intervention was done during the patient’s office visit. Often the project manager was 45 
minutes late seeing subsequent patients on the daily office visit schedule. Educational 
interventions do take more time but there is a quality measure obtained for the time 
spent doing the intervention. A proposed solution to better time utilization would be 
scheduling the patient as the last patient of the morning or the afternoon schedule. The 
extra time used would not interfere with the next patient and allow for an educational 
intervention without being rushed. Current and future quality measures include 
necessary medication educational documentation and a questionnaire which can be 
interfaced into the EMR. All of these measures currently are and will continue to be a 
product for reimbursement.   
Implications for the Future       
  Practice. For the APN as well as the RN, Lane et al (2006) as well as Cook-
Campbell and Sefton (2010) discussed whether the patient was really taught what they 
needed to know about OAT. Hu et al. (2006) discussed insufficient patient knowledge of 
OAT. When reflecting on the log for this project, all of these points vividly show the need 
for initial and ongoing assessment and education on OAT. Charts and graphs in this 
EBP project showed monitoring infrequency of OAT with concern for patient adherence; 
both of these issues offer implications for practice. Pretest/posttest scores showed 
improvement and were statistically significant for learning measured. However, ongoing 
INR values did not consistently improve. INR values traced over 12 weeks showed the 
patient in therapeutic range approximately 29-67% of the time.  
  This EBP project reflected the study done by Pernod et al. (2006) which showed 
the population in that study to be in range approximately 64% of the time. One of the 
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reasons for patients not to be in therapeutic INR range was found by both the APN as 
well as the RN in the project manager’s outpatient office. Patients’ need to write down 
directions for dosing after the most recent INR value has been obtained. The APN and 
the RN found patients who acknowledged the phone call but not the dosage change, 
and patients continued their former dose without any change to the next INR value. 
Further questioning of the patients determined they did not know how to interpret new 
dosing directions. Phone calls to family members discovered many patients did not 
understand their new directions for OAT were to be done immediately and the next INR 
to be obtained in the time frame directed.   
 Theory. The Roy Adaptation model facilitated patients’ adaptation responses 
and promoted patient coping strategies. Patients note many physiological changes when 
taking OAT, and understand their functional integrity has been challenged with a 
medication which can cause bleeding. The Roy model provides the patient with a self-
concept which promotes body image as well as expectations within relationships and 
culture. Particularly for the APN and RN, theory can identify patient problems, facilitate 
change, and provide a guide for direction to improve patient outcomes with a greater 
understanding of application to practice. Using theory enhances the credibility of both 
the RN and APN when results of the problem as well as the solution are found in the 
literature. Findings from this EBP project can influence future theory development in (a) 
practice change related to polypharmacy or reimbursement, (b) increased staff 
awareness to assist patients who need to overcome obstacles, (c) support readiness for 
change by patients, or (d) increase awareness of strategies for time-consuming office 
and patient care issues.  
 Research. The project on OAT has implications for both the APN and the RN as 
they both care for the patients with atrial fibrillation, stroke, clotting disorders, and valve 
replacements in the outpatient setting. Further research can be done specifically with 
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these populations, just as Hu et al. (2006) reported on patients with mechanical valves 
and used the 20-question KIP to assess patient knowledge. With 68% of the population 
having atrial fibrillation in the EBP project, further research should be conducted with this 
population and then have expansion to other populations.  
 The six new patients mentioned previously who started warfarin since the project 
closed were on a new anticoagulant with their atrial fibrillation onset, but none of the 
patients could afford the new medication or did their insurance have any of the new 
anticoagulants on their formulary. Future research could examine cardiology prescribing 
efforts in patient anticoagulation and safety related to insurance formulary practices. If 
patients are not able to afford their medications, they will not comply with OAT.   
 Education. Education on OAT in the outpatient clinic setting provided timely 
feedback of patient needs when using questionnaires and a direct one-on-one 
educational intervention. Future implications for education from this study show the need 
for ongoing OAT education, suggesting a refresher every three months as did the work 
by Clarkesmith, Pattison, Lip, and Lane (2013). Ongoing education will be recommended 
with policies and procedures in place upon the start of the new Coumadin® clinic among 
the medical center providers and community.  
  There is also no standard for education in questionnaires used to determine 
patient knowledge. Many questionnaires previously used in the literature contained 38 -
56 items and the literacy levels of these questionnaires were not determined (Smith et 
al., 2010). Evidence supports using questionnaires that are consistent and reliable. 
Direct implications for future research can advise standardization of questionnaires, and 
measure the literacy level of not only the questionnaire but also the educational 
materials to better accommodate the population studied.  
 
 




 The primary outcome of this EBP project was that an educational intervention did 
make a significant difference in oral anticoagulation therapy knowledge in primary care. 
Overall, 26 of the 38 patients (68%) passed the pretest and 35 of the 38 (92%) patients 
passed the posttest. The educational intervention showed statistical significance which 
mirrored findings in the literature. The educational intervention facilitated the patients as 
they moved through the phases of adaptation in a positive manner when confronted with 
environmental stimuli. The educational intervention made the patients’ learning skills 
manageable as well as attainable. Patients also had information about OAT in a large 
print booklet as well as in multimedia format to use for a refresher at home as a result of 
the educational intervention.  
 Secondary outcomes of the EBP project revealed the patients’ INR values did not 
show a statistically significant change in improved stability nor control in therapeutic 
range from pretest and in two weeks at the post-test. However, the results did 
demonstrate an initial clinical improvement in INR values and a general trend to early 
improvement. However, outcomes in INR values also did not show continued stability or 
control toward the end of the 12 weeks. These findings support the studies by Smith et 
al. (2010) which expressed a high variability in effectiveness with warfarin therapy. 
Related to these outcomes, data from this EBP project also supports the need for (a) 
continued patient education every three months (Clarkesmith, Pattison, & Lane, 2013), 
(b) controlled efficacy of the educational program (Hu et al., 2006), (c) evaluating the 
literacy level of the educational materials (Lane et al., 2005), and (d) more frequent INR 
testing (Pernod et al., 2008).    
 Secondary outcomes also revealed that 10 patients admitted never having any 
prior educational intervention on OAT. Again, patients were able to face environmental 
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stimuli and successfully process new learning skills with an educationally-leveled 
questionnaire and booklet. Patients in this EBP project had positive outcomes in their 
questionnaire scores. Having the spouse or significant other in the room during the 
educational intervention did not make a statistically significant difference in the patients’ 
questionnaire scores. However, the majority of patients were able to achieve passing 
scores on both their pretest and posttest questionnaires related to the lower educational 
level of the teaching tools as well as questionnaire.  
  Cook-Campbell and Sefton (2010) sited that older adults may have different 
learning needs related to the aging process and comorbidities and that their mental 
capacity may be a barrier. Their study did not use a questionnaire that had established 
reliability or validity. In this EBP project, mental capacity of the older adult due to age, 
comorbidities, or mental capacity was not a factor when using a lower literacy level 
questionnaire to measure patient knowledge. This EBP project also showed the 
questionnaire, the KIP-C, as stable over time, and constant over multiple administrations 
as did previous literature (Hu et al., 2006; Wilson et al., 2003; Wilson et al., 2014). 
 Education with health promotion is a privilege as well as a duty of nursing to 
foster the best of all possible outcomes in patient care. As nursing becomes more aware 
of patient risk with the ever-present use of polypharmacy, the patients’ longer life span, 
and multiple chronic disease comorbidities, education in the outpatient arena is and will 
continue to be a quality measure in cost-savings for the patients as well as the 
healthcare system. Consistently striving for positive outcomes in an unpredictable 
environment of patient decisions and modifiable risk, patient education will continue to 
be goal-driven in nursing.    
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ACCP: American College of Chest Physicians 
AF:  Atrial Fibrillation  
AKA: Anticoagulant Knowledge Assessment 
APN: Advanced Practice Nurse   
AHRQ:  Agency for Healthcare Research and Quality 
AS:  AGREE II score 
CBC: Complete Blood Count 
CHADS2: Congestive heart failure, Hypertension, Diabetes, Stroke, 2nd revision 
DVD:  Digital Video Disc 
DVT:  Deep Vein Thrombosis  
EBP: Evidence-Based Practice 
HIPPA:  Health Insurance Portability and Accountability Act  
INR:  International Normalized Ratio blood test 
IRB:  Institutional Review Board 
KIP: Knowledge Information Profile  
KIP-C: Knowledge Information Profile-Coumadin® 
NSAIDS: Non-Steroidal Anti-Inflammatory Drugs 
OAT:  Oral Anticoagulation Therapy  
PICOT:  Patient population, Intervention or Issue of interest, Comparison, Outcome, and  
   Time frame  
PT:  Prothrombin Time (blood test) 
REALM: Rapid Estimate of Adult Literacy in Medicine  
RU:  Research Utilization 
SPSS: Statistical Package for the Social Sciences  
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TREAT: TRial of an Educational intervention on patients’ knowledge of Atrial fibrillation 
and anticoagulation therapy, INR control and outcome of Treatment with warfarin study 






















































Knowledge Information Profile-Coumadin® (KIP-C®)   
 
Directions:  Circle either True or False 
 
1. True or  False  The medicine will make my blood clot. 
 
2. True  or  False   I can take over-the-counter medicines like aspirin while  
   I am taking Coumadin®. 
 
3. True or  False  Coumadin® is an anticoagulant medication. 
 
4. True or  False  If I want to go on a diet, now would be a good time  
     while I am taking Coumadin®. 
 
5. True  or False  I can take any amount of laxatives and aspirin while  
    taking Coumadin®. 
 
6. True  or  False Lots of Vitamin K is good for me while taking   
   Coumadin®. 
 
7. True  or  False Vitamin K helps Coumadin® prevent blood clots. 
 
8. True  or  False It is not safe to drink liquor while on this medicine, but I can 
have    as much beer or wine as I want. 
 
9. True  or  False Foods like fish, mineral water and tomatoes are high in  
   Vitamin K. 
 
10. True  or  False I can eat any amount of collard greens as I want while  
   taking Coumadin®. 
 
11. True  or  False Indigestion is a side-effect of Coumadin®. 
 
12. True  or  False Bleeding from the gum after brushing my teeth in a side- 
   effect of Coumadin®. 
 
13. True  or  False Swelling of the hand and feet is a side-effect of   
   Coumadin®.  




14. True  or  False I can take any kind of vitamins I want while I am on   
  Coumadin® 
 
 
Demographics:  Circle one answer  
 
Age:    _______________years  
 
 
Last grade of school completed: __________________ 
 
 
Gender:  Male or  Female 
 
 
Have you ever had patient information of warfarin or Coumadin® in the past?  
 
 Yes     No  
 
 
How long ago did you receive patient information on Coumadin® ?__________ 
 
 
How long have you used Coumadin® ?______________________  
 
 
Reason for Coumadin®/warfarin therapy:  Atrial fibrillation 
      Valve replacement 
      Blood clots 
      Stroke 
      Other 
 
 
If this is your first visit for the pretest, will your spouse/partner also hear the 
teaching session?  
 





















































































Written Informed Consent 
 
Title of Project: “The Effect of an Educational Intervention on Oral Anticoagulation 
Therapy Knowledge in Primary Care” 
 
Principal Investigator:  Elizabeth Deck, FNP-BC, CDE 
 
IRB #164 
1.  Purpose of the Study: You are invited to participate in a study involving 
research. The purpose of this study is to determine if knowledge is gained using 
the pre-test/post-test Knowledge Information Profile-Coumadin®, (KIP-C®), a 
14-question true/false tool.  The KIP-C® measures what you know about Vitamin 
K foods, side effects, and other foods, liquids to drink, and medications related to 
Coumadin® or warfarin. You will make choices of eight facts including your age 
range, how much schooling you have had, gender, if you have had 
Coumadin®/warfarin teaching in the past, range of time using 
Coumadin®/warfarin therapy, how long ago you had the teaching, reasons for 
using Coumadin®/warfarin and if your spouse/partner will also hear the teaching 
intervention. The principal investigator will show you the handout on 
Coumadin/warfarin, plus use food models to show food servings that may help 
you gain more knowledge about using this medication. Besides the eight facts 
about you, the pre-test/post-test scores will be used in this study. The duration of 
the study is 12 weeks.  About 40 patients will be in this study if they consent. The 
study will only be in this office. .  
2.  The procedures to be followed include: You will read and sign a consent form 
from Riverside Medical Center.  You will then take the Knowledge Information 
Profile-Coumadin® in the office, 300 Riverside Drive, Suite 2400, Bourbonnais, 
Illinois. The principal investigator will give you a handout called: “Blood Thinner 
Pills: Your Guide to Using Them Safely”, a handout available to the public from 
Agency for Healthcare Research and Quality (AHRQ). The principal investigator 
will also show you the handout and food models as examples of foods and drinks 
to show the same use of these foods each week.  In two weeks you will come back 
to the office and take the post-test.    
 Reason to Participate/Benefits: The benefits you may receive include more 
 knowledge about Coumadin® or warfarin including foods, beverages, and 
 medication side effects. Coumadin® or warfarin is a pill that helps you keep 
 your blood thinner to help stop problems of your heart or blood vessels. 
 Sometimes food, drinks or other pills may pose a problem that you do not  know.   
3.  Participation is voluntary.  Your becoming a subject in this study is entirely by 
your own free choice.  You may also drop out of this study by your own free will, 
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after having agreed to become a subject.  You may refuse to enroll in this study or 
drop out of the study at any time without any problem; by doing so, you will not 
lose any benefits that you may be entitled. The principal investigator in this study 
may have to end your taking part in the study as a subject if you become ill during 
the pre-test/post-test or showing you the food models and cannot finish the office 
visit. Anything the principal investigator finds during the course of the study 
which may relate to your agreeing to continue doing the study will be provided to 
you.   
4.  Procedures to be followed: If you participate in the study, you will be asked 
true/false questions about what you know of Coumadin® or warfarin therapy. 
This is the pre-test. You will also be asked 8 questions of facts about yourself. 
The blood thinner handout and the food model demonstration will be done over 
25 minutes; this will include a 12-minute video on Coumadin/warfarin therapy. 
You will be able to take the handout and the video home with you.  You will then 
return to the office in two weeks and take the post-test. This completes the study 
for you. You do not have to use these resources in any way.  Any harm or 
discomfort thought to happen with your help in this study is not greater than what 
you do during the day or for a routine office visit, blood pressure check or blood 
check for your Coumadin®/warfarin.   
5. Potential risks, discomfort, and inconveniences: Any risks, discomfort, or 
burden if you choose to take part in the study will not be greater than those 
experienced in daily life or during an exam in the office. The chances for harm for 
completing the study are not greater than those that may happen during an office 
visit. This is considered no more than minimal risk. If you experience discomfort 
or are injured during the study you are to contact the office administrator at 815-
935-2784 during office hours within 24 hours of your appointment.  
6. Statement of confidentiality: All of your records will be in a password-protected 
electronic medical record and be kept confidential. Signed copies of your consents 
authorizations will be kept in a locked office file cabinet for three years and then 
destroyed. We shall put the information collected about you during the study into 
a research record.  This research record will not show your name, but will have a 
code entered in it, that will allow the information to be linked to you. However, 
we shall keep your research record confidential, to the extent provided by federal, 
state and local law. No one other than the principal investigator will be allowed to 
see the information, subject to legally proscribed exceptions. You will not be 
identified in any reports on this study. The primary physician will be contacted if 
project investigator in the course of this project learns of a medical condition that 
requires immediate attention.  
7. Personal benefits: Personal benefits include learning food, drug and medication 
side effects of Coumadin®/warfarin therapy. The overall benefit includes helping 
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you know more about Coumadin®/warfarin therapy. You may notice you benefit 
from the study, or what you learned may help others who also are on 
Coumadin®/warfarin.  
8. Compensation for taking part in the study: You will not get paid for taking part 
in the study.    
9. Health insurance bills:  The insurance will not be billed for any extra time spent 
with you.  If you do the pre-test/post-test during the regular routine office visit, 
the insurance will only be billed for the routine office visit information. There is 
no fee for the high blood pressure monitoring visit if you take your test during 
that visit. The blood test (INR) is ordered by the doctor and the patient’s 
insurance pays for this test. No additional fees will be added to your insurance bill 
or the pre-test/post-test or food model demonstration.    
10. New risks uncovered: If any new risks are found during the course of the 
research-based practice study which may show the risks of harm have increased, 
the investigator will let you know so that you may reconsider your willingness to 
stay in the study.  To find out any aspect of this study you may contact:  Elizabeth 
Deck, FNP-BC, CDE, 300 Riverside Drive, Suite 2400, Bourbonnais, Illinois, 
60914, office phone 815-935-2784 during business hours. If you have any 
questions or concerns about your rights as a study subject or grievances, you may 
contact Karen Block, Riverside’s HIPPA Privacy Officer at 815-933-1671. 
11. Alternative procedures/treatment: You may choose not to participate in this 
study.  Alternatives to the study include the regular office visit, the blood pressure 
check or the blood check for your medication tracking.   
12. Principal Investigator’s participation/payment: The principal investigator will 
not get paid for doing this from Riverside or Valparaiso University.   
13. Where copies of documents are kept: One copy of the informed consent will be 
kept locked with the principal investigator’s research records.  A second copy will 
be given to you to keep.  A third copy will be placed into your record at Riverside 
Medical Center. Data will be maintained for three years in a locked office file 
cabinet then destroyed. 
14. Study subjects’ statement of consent to participate in the study: I have read the 
information given above. The investigator has personally discussed with me and told 
me more about the study, and answered my questions. I understand the meaning of 
this information. I am aware that, like in any research-based practice study, the 
investigator cannot always predict what may happen or possibly go wrong.  I have 
been given enough time to consider if I should join this study.  I hereby consent by 
my own free choice to take part in the study as a study subject.  I am not waiving any 
of my legal rights by signing this form. I understand I will receive a copy of this 
consent form.  
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15.  Signatures required on the informed consent document:  




































Authorization Form   
The Privacy Law, Health Insurance Portability & Accountability ACT (HIPPA), protects 
my individually identifiable health information (protected health information).  The 
Privacy Law requires me to sign an authorization (or agreement) so researchers can use 
or disclose my protected health information for research purposes.  My protected health 
information will be used/disclosed for the following research study:  The Effect of an 
Educational Intervention on Oral Anticoagulation Therapy Knowledge in Primary Care. 
I authorize Elizabeth Deck, FNP-BC, CDE, to create, access, use and disclose my 
protected health information for the purposes described below. 
My protected health information that may be used/or and disclosed includes: 
*Age group, educational level, gender, length of time using Coumadin®/warfarin, and 
indication for Coumadin®/warfarin, and score on the pre-test/post-test, which is coded 
alphabetically and not disclosed to anyone but primary researcher. 
My protected health information will be used for: 
*The purpose the study is to determine if knowledge is gained using the pre-test/post-test 
Knowledge Information Profile-Coumadin® (KIP-C®), a 14-question true/false tool or 
questionnaire.  The KIP-C® assesses patients’ knowledge of Vitamin K foods, side 
effects, and other foods, liquids to drink, and medications related to Coumadin or 
warfarin.  Eight areas of facts including age group, how much education you have had, 
gender, if you have had patient information on Coumadin®/warfarin, length of time using 
Coumadin®/warfarin, reasons for Coumadin®/warfarin therapy, and if your 
spouse/partner will also hear the educational intervention will be used in this study.  The 
principal investigator will give you a handout on Coumadin®/warfarin, plus use food 
models to show possible food, drinks and medication side effects to taking 
Coumadin®/warfarin on a daily basis. The PHI (protected health information) is 
necessary to conduct the research and meet legal, institutional and accreditation 
requirements.  
The Researchers may use and share my health information with:    
 *Representatives of Riverside Medical Center or Riverside Medical Center’s 
Institutional Review Board 
 *My primary physician will be contacted if researcher in the course of the project 
learns of a medical condition that needs immediate attention 
Should my health information be disclosed to anyone outside of the study, the 
information may no longer be protected by HIPPA and this authorization; however, the 
use of my health information would still be regulated by applicable federal and state 
laws.  
I do not have to sign this Authorization.  If I decide to sign the Authorization:  
It will not affect my treatment, payment or enrollment in any health plans or affect my 
eligibility for benefits. I will still be able to ask my doctor questions about my 
Coumadin® or warfarin treatment.  
I may not be allowed to participate in the research study.  
After signing the Authorization, I can change my mind and: 
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*Not let the researcher disclose or use my protected health information (revoke the 
Authorization). 
*If I revoke the Authorization, I will send a written letter to:  Elizabeth Deck, FNP-BC, 
CDE, 300 Riverside Drive, Suite 2400, Bourbonnais, Illinois, 60914, to inform her of my 
decision. 
*If I revoke the Authorization, the researcher may only use and disclose the protected 
health information already collected for this research study.  
*If I revoke this Authorization, my protected health information may still be used and 
disclosed should I have any adverse event (a bad effect). 
*If I change my mind and withdraw the Authorization, I may not be allowed to 
participate in the study.  
This authorization does not have an expiration date but can be terminated if I decide to 
withdraw my permission. 
If I have not already received a copy of the Privacy Notice, I may request one from 
Elizabeth Deck, FNP-BC; CDE at 815-935-2784.  If I have questions or concerns about 
my privacy rights, I should contact Karen Block, Riverside’s HIPPA privacy officer at 
350 N. Wall Street, Kankakee, IL 60901, 815-933-1671.  
I have read this information, and I will receive a copy of this form after it is signed.  I 




________________________________    _____________________ 
 Signature of subject     Date 
 
 
________________________________    
 Printed name of subject 
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